{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:20:08Z","timestamp":1790864408157,"version":"4.1.0"},"reference-count":325,"publisher":"Bentham Science Publishers Ltd.","issue":"34","funder":[{"DOI":"10.13039\/501100001807","name":"S\u00e3o Paulo Research Foundation","doi-asserted-by":"publisher","award":["2018\/07366-4"],"award-info":[{"award-number":["2018\/07366-4"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["306392\/2017-8"],"award-info":[{"award-number":["306392\/2017-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Systemic arterial hypertension (SAH) is a major risk factor for several secondary\ndiseases, especially cardiovascular and renal conditions. SAH has a high prevalence\nworldwide, and its precise and early recognition is important to prevent the development\nof secondary outcomes. In this field, the study of biomarkers represents an important\napproach to diagnosing and predicting the disease and its associated conditions. The\nuse of biomarkers in hypertension and hypertension-related disorders, such as ischemic\nstroke, intracerebral hemorrhage, transient ischemic attack, acute myocardial infarction,\nangina pectoris and chronic kidney disease, are discussed in this review. Establishing a\npotential pool of biomarkers may contribute to a non-invasive and improved approach\nfor their diagnosis, prognosis, risk assessment, therapy management and pharmacological\nresponses to a therapeutic intervention to improve patients' quality of life and prevent unfavorable\noutcomes.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867329666220921113403","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T04:29:43Z","timestamp":1663907383000},"page":"3846-3879","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Biomarkers in Hypertension and Hypertension-related Disorders"],"prefix":"10.2174","volume":"30","author":[{"given":"Patr\u00edcia","family":"de Carvalho Ribeiro","sequence":"first","affiliation":[{"name":"Department of Oncology, Georgetown University, Washington, DC, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas Felipe","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Department of Physiology,\nBiological and Natural Sciences Institute, Triangulo Mineiro Federal University, Uberaba, MG,\nBrazil"},{"name":"National Institute of Science and Technology for Regenerative Medicine, Rio de Janeiro, RJ,\nBrazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Mendes","family":"Filho","sequence":"additional","affiliation":[{"name":"Department of Physiology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto,\nSao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo Cambraia","family":"Parreira","sequence":"additional","affiliation":[{"name":"University Centre of Mineiros (UNIFIMES), Trindade, GO, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Sousa","family":"Vieira","sequence":"additional","affiliation":[{"name":"Department of\nBiochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo\nHorizonte, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Lemes","family":"Marques","sequence":"additional","affiliation":[{"name":"Laboratory of Neuropharmacology and Neurochemistry, Institute of Biological Sciences,\nFederal University of Goi\u00e1s, Goi\u00e2nia, GO, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elis Marra","family":"da Madeira Freitas","sequence":"additional","affiliation":[{"name":"Laboratory of Neuropharmacology and Neurochemistry, Institute of Biological Sciences, Federal University of Goi\u00e1s, Goi\u00e2nia, GO, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walison N.","family":"Silva","sequence":"additional","affiliation":[{"name":"Department of Pathology, Federal University of\nMinas Gerais, Belo Horizonte, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helton da Costa","family":"Santiago","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Immunology, Federal University of\nMinas Gerais, Belo Horizonte, Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Birbrair","sequence":"additional","affiliation":[{"name":"Department of Pathology, Federal University of\nMinas Gerais, Belo Horizonte, Brazil"},{"name":"Department of Radiology, Columbia University Medical\nCenter, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Ulrich","sequence":"additional","affiliation":[{"name":"National Institute of Science and Technology for Regenerative Medicine, Rio de Janeiro, RJ,\nBrazil"},{"name":"Department of Biochemistry, Institute of Chemistry, University of Sao\nPaulo, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valdo Jos\u00e9 Dias","family":"da Silva","sequence":"additional","affiliation":[{"name":"Department of Physiology, Biological and Natural Sciences Institute, Triangulo Mineiro Federal University, Uberaba, MG,\nBrazil"},{"name":"National Institute of Science and Technology for Regenerative Medicine, Rio de Janeiro, RJ,\nBrazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo R.","family":"Resende","sequence":"additional","affiliation":[{"name":"Department of\nBiochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo\nHorizonte, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"3S","volume":"19","author":"Williams B.","year":"2018","unstructured":"Williams B.; Mancia G.; Spiering W.; Rosei E.A.; Azizi M.; Burnier M.; Clement D.L.; Coca A.; de Simone G.; Dominiczak A.; Kahan T.; Mahfoud F.; Redon J.; Ruilope L.; Zanchetti A.; Kerins M.; Kjeldsen S.E.; Kreutz R.; Laurent S.; Lip G.Y.H.; McManus R.; Narkiewicz K.; Ruschitzka F.; Schmieder R.E.; Shlyakhto E.; Tsioufis C.; Aboyans V.; Desormais I.; 2018 ESC\/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). G Ital Cardiol (Rome) 2018,19(11),3S-73S","journal-title":"G Ital Cardiol (Rome)"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jama.2013.184182","volume":"310","author":"Chow C.K.","year":"2013","unstructured":"Chow C.K.; Teo K.K.; Rangarajan S.; Islam S.; Gupta R.; Avezum A.; Bahonar A.; Chifamba J.; Dagenais G.; Diaz R.; Kazmi K.; Lanas F.; Wei L.; Lopez-Jaramillo P.; Fanghong L.; Ismail N.H.; Puoane T.; Rosengren A.; Szuba A.; Temizhan A.; Wielgosz A.; Yusuf R.; Yusufali A.; McKee M.; Liu L.; Mony P.; Yusuf S.; Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 2013,310(9),959-968","journal-title":"JAMA"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1093\/ije\/dyy016","volume":"47","author":"Zhou B.","year":"2018","unstructured":"Zhou B.; Bentham J.; Di Cesare M.; Bixby H.; Danaei G.; Hajifathalian K.; Taddei C.; Carrillo-Larco R.M.; Djalalinia S.; Khatibzadeh S.; Lugero C.; Peykari N.; Zhang W.Z.; Bennett J.; Bilano V.; Stevens G.A.; Cowan M.J.; Riley L.M.; Chen Z.; Hambleton I.R.; Jackson R.T.; Kengne A.P.; Khang Y-H.; Laxmaiah A.; Liu J.; Malekzadeh R.; Neuhauser H.K.; Sori\u0107 M.; Starc G.; Sundstr\u00f6m J.; Woodward M.; Ezzati M.; Abarca-G\u00f3mez L.; Abdeen Z.A.; Abu-Rmeileh N.M.; Acosta-Cazares B.; Adams R.J.; Aekplakorn W.; Afsana K.; Aguilar-Salinas C.A.; Agyemang C.; Ahmad N.A.; Ahmadvand A.; Ahrens W.; Ajlouni K.; Akhtaeva N.; Al-Raddadi R.; Ali M.M.; Ali O.; Alkerwi A.; Aly E.; Amarapurkar D.N.; Amouyel P.; Amuzu A.; Andersen L.B.; Anderssen S.A.; \u00c4ngquist L.H.; Anjana R.M.; Ansong D.; Aounallah-Skhiri H.; Ara\u00fajo J.; Ariansen I.; Aris T.; Arlappa N.; Arveiler D.; Aryal K.K.; Aspelund T.; Assah F.K.; Assun\u00e7\u00e3o M.C.F.; Avdicov\u00e1 M.; Azevedo A.; Azizi F.; Babu B.V.; Bahijri S.; Balakrishna N.; Bamoshmoosh M.; Banach M.; Bandosz P.; Banegas J.R.; Barbagallo C.M.; Barcel\u00f3 A.; Barkat A.; Barros A.J.D.; Barros M.V.; Bata I.; Batieha A.M.; Batyrbek A.; Baur L.A.; Beaglehole R.; Romdhane H.B.; Benet M.; Benson L.S.; Bernabe-Ortiz A.; Bernotiene G.; Bettiol H.; Bhagyalaxmi A.; Bharadwaj S.; Bhargava S.K.; Bi Y.; Bikbov M.; Bista B.; Bjerregaard P.; Bjertness E.; Bjertness M.B.; Bj\u00f6rkelund C.; Blokstra A.; Bo S.; Bobak M.; Boeing H.; Boggia J.G.; Boissonnet C.P.; Bongard V.; Borchini R.; Bovet P.; Braeckman L.; Brajkovich I.; Branca F.; Breckenkamp J.; Brenner H.; Brewster L.M.; Bruno G.; Bueno-de-Mesquita H.B.; Bugge A.; Burns C.; Bursztyn M.; de Le\u00f3n A.C.; Cacciottolo J.; Cai H.; Cameron C.; Can G.; C\u00e2ndido A.P.C.; Capuano V.; Cardoso V.C.; Carlsson A.C.; Carvalho M.J.; Casanueva F.F.; Casas J-P.; Caserta C.A.; Chamukuttan S.; Chan A.W.; Chan Q.; Chaturvedi H.K.; Chaturvedi N.; Chen C-J.; Chen F.; Chen H.; Chen S.; Chen Z.; Cheng C-Y.; Dekkaki I.C.; Chetrit A.; Chiolero A.; Chiou S-T.; Chirita-Emandi A.; Chirlaque M-D.; Cho B.; Cho Y.; Christofaro D.G.; Chudek J.; Cifkova R.; Cinteza E.; Claessens F.; Clays E.; Concin H.; Cooper C.; Cooper R.; Coppinger T.C.; Costanzo S.; Cottel D.; Cowell C.; Craig C.L.; Crujeiras A.B.; Cruz J.J.; D\u2019Arrigo G.; d\u2019Orsi E.; Dallongeville J.; Damasceno A.; Danaei G.; Dankner R.; Dantoft T.M.; Dauchet L.; Davletov K.; De Backer G.; De Bacquer D.; de Gaetano G.; De Henauw S.; de Oliveira P.D.; De Smedt D.; Deepa M.; Dehghan A.; Delisle H.; Deschamps V.; Dhana K.; Di Castelnuovo A.F.; Dias-da-Costa J.S.; Diaz A.; Dickerson T.T.; Djalalinia S.; Do H.T.P.; Donfrancesco C.; Donoso S.P.; D\u00f6ring A.; Dorobantu M.; Doua K.; Drygas W.; Dulskiene V.; D\u017eakula A.; Dzerve V.; Dziankowska-Zaborszczyk E.; Eggertsen R.; Ekelund U.; El Ati J.; Elliott P.; Elosua R.; Erasmus R.T.; Erem C.; Eriksen L.; Eriksson J.G.; Escobedo-de la Pe\u00f1a J.; Evans A.; Faeh D.; Fall C.H.; Farzadfar F.; Felix-Redondo F.J.; Ferguson T.S.; Fernandes R.A.; Fern\u00e1ndez-Berg\u00e9s D.; Ferrante D.; Ferrari M.; Ferreccio C.; Ferrieres J.; Finn J.D.; Fischer K.; F\u00f6ger B.; Foo L.H.; Forslund A-S.; Forsner M.; Fouad H.M.; Francis D.K.; do Carmo Franco M.; Franco O.H.; Frontera G.; Fuchs F.D.; Fuchs S.C.; Fujita Y.; Furusawa T.; Gaciong Z.; Galvano F.; Garcia-de-la-Hera M.; Gareta D.; Garnett S.P.; Gaspoz J-M.; Gasull M.; Gates L.; Geleijnse J.M.; Ghasemian A.; Ghimire A.; Giampaoli S.; Gianfagna F.; Gill T.K.; Giovannelli J.; Goldsmith R.A.; Gon\u00e7alves H.; Gonzalez-Gross M.; Gonz\u00e1lez-Rivas J.P.; Gorbea M.B.; Gottrand F.; Graff-Iversen S.; Grafnetter D.; Grajda A.; Grammatikopoulou M.G.; Gregor R.D.; Grodzicki T.; Gr\u00f8ntved A.; Grosso G.; Gruden G.; Grujic V.; Gu D.; Guan O.P.; Gudmundsson E.F.; Gudnason V.; Guerrero R.; Guessous I.; Guimaraes A.L.; Gulliford M.C.; Gunnlaugsdottir J.; Gunter M.; Gupta P.C.; Gupta R.; Gureje O.; Gurzkowska B.; Gutierrez L.; Gutzwiller F.; Hadaegh F.; Halkj\u00e6r J.; Hambleton I.R.; Hardy R.; Hari Kumar R.; Hata J.; Hayes A.J.; He J.; He Y.; Elisabeth M.; Henriques A.; Cadena L.H.; Herrala S.; Heshmat R.; Hihtaniemi I.T.; Ho S.Y.; Ho S.C.; Hobbs M.; Hofman A.; Dinc G.H.; Horimoto A.R.V.R.; Hormiga C.M.; Horta B.L.; Houti L.; Howitt C.; Htay T.T.; Htet A.S.; Than Htike M.M.; Hu Y.; Huerta J.M.; Huisman M.; Husseini A.S.; Huybrechts I.; Hwalla N.; Iacoviello L.; Iannone A.G.; Ibrahim M.M.; Wong N.I.; Ikeda N.; Ikram M.A.; Irazola V.E.; Islam M.; al-Safi Ismail A.; Ivkovic V.; Iwasaki M.; Jackson R.T.; Jacobs J.M.; Jaddou H.; Jafar T.; Jamrozik K.; Janszky I.; Jasienska G.; Jelakovi\u0107 A.; Jelakovi\u0107 B.; Jennings G.; Jeong S.; Jiang C.Q.; Joffres M.; Johansson M.; Jokelainen J.J.; Jonas J.B.; J\u00f8rgensen T.; Joshi P.; J\u00f3\u017awiak J.; Juolevi A.; Jurak G.; Jure\u0161a V.; Kaaks R.; Kafatos A.; Kajantie E.O.; Kalter-Leibovici O.; Kamaruddin N.A.; Karki K.B.; Kasaeian A.; Katz J.; Kauhanen J.; Kaur P.; Kavousi M.; Kazakbaeva G.; Keil U.; Boker L.K.; Kein\u00e4nen-Kiukaanniemi S.; Kelishadi R.; Kemper H.C.G.; Kengne A.P.; Kerimkulova A.; Kersting M.; Key T.; Khader Y.S.; Khalili D.; Khang Y-H.; Khateeb M.; Khaw K-T.; Kiechl-Kohlendorfer U.; Kiechl S.; Killewo J.; Kim J.; Kim Y-Y.; Klumbiene J.; Knoflach M.; Kolle E.; Kolsteren P.; Korrovits P.; Koskinen S.; Kouda K.; Kowlessur S.; Koziel S.; Kriemler S.; Kristensen P.L.; Krokstad S.; Kromhout D.; Kruger H.S.; Kubinova R.; Kuciene R.; Kuh D.; Kujala U.M.; Kulaga Z.; Krishna Kumar R.; Kurjata P.; Kusuma Y.S.; Kuulasmaa K.; Kyobutungi C.; Laatikainen T.; Lachat C.; Lam T.H.; Landrove O.; Lanska V.; Lappas G.; Larijani B.; Laugsand L.E.; Laxmaiah A.; Le Nguyen Bao K.; Le T.D.; Leclercq C.; Lee J.; Lee J.; Lehtim\u00e4ki T.; Le\u00f3n-Mu\u00f1oz L.M.; Levitt N.S.; Li Y.; Lilly C.L.; Lim W-Y.; Lima-Costa M.F.; Lin H-H.; Lin X.; Lind L.; Linneberg A.; Lissner L.; Litwin M.; Liu J.; Lorbeer R.; Lotufo P.A.; Lozano J.E.; Luksiene D.; Lundqvist A.; Lunet N.; Lytsy P.; Ma G.; Ma J.; Machado-Coelho G.L.L.; Machi S.; Maggi S.; Magliano D.J.; Magriplis E.; Majer M.; Makdisse M.; Malekzadeh R.; Malhotra R.; Mallikharjuna Rao K.; Malyutina S.; Manios Y.; Mann J.I.; Manzato E.; Margozzini P.; Marques-Vidal P.; Marques L.P.; Marrugat J.; Martorell R.; Mathiesen E.B.; Matijasevich A.; Matsha T.E.; Mbanya J.C.N.; Mc Donald Posso A.J.; McFarlane S.R.; McGarvey S.T.; McLachlan S.; McLean R.M.; McLean S.B.; McNulty B.A.; Mediene-Benchekor S.; Medzioniene J.; Meirhaeghe A.; Meisinger C.; Menezes A.M.B.; Menon G.R.; Meshram I.I.; Metspalu A.; Meyer H.E.; Mi J.; Mikkel K.; Miller J.C.; Minderico C.S.; Francisco J.; Miranda J.J.; Mirrakhimov E.; Mi\u0161igoj-Durakovic M.; Modesti P.A.; Mohamed M.K.; Mohammad K.; Mohammadifard N.; Mohan V.; Mohanna S.; Mohd Yusoff M.F.; M\u00f8llehave L.T.; M\u00f8ller N.C.; Moln\u00e1r D.; Momenan A.; Mondo C.K.; Monyeki K.D.K.; Moon J.S.; Moreira L.B.; Morejon A.; Moreno L.A.; Morgan K.; Moschonis G.; Mossakowska M.; Mostafa A.; Mota J.; Esmaeel Motlagh M.; Motta J.; Msyamboza K.P.; Mu T.T.; Muiesan M.L.; M\u00fcller-Nurasyid M.; Murphy N.; Mursu J.; Musil V.; Nabipour I.; Nagel G.; Naidu B.M.; Nakamura H.; N\u00e1me\u0161n\u00e1 J.; Nang E.E.K.; Nangia V.B.; Narake S.; Nauck M.; Navarrete-Mu\u00f1oz E.M.; Ndiaye N.C.; Neal W.A.; Nenko I.; Neovius M.; Nervi F.; Neuhauser H.K.; Nguyen C.T.; Nguyen N.D.; Nguyen Q.N.; Nguyen Q.V.; Nieto-Mart\u00ednez R.E.; Niiranen T.J.; Ning G.; Ninomiya T.; Nishtar S.; Noale M.; Noboa O.A.; Noorbala A.A.; Norat T.; Noto D.; Al Nsour M.; O\u2019Reilly D.; Oda E.; Oehlers G.; Oh K.; Ohara K.; Olinto M.T.A.; Oliveira I.O.; Omar M.A.; Onat A.; Ong S.K.; Ono L.M.; Ordunez P.; Ornelas R.; Osmond C.; Ostojic S.M.; Ostovar A.; Otero J.A.; Overvad K.; Owusu-Dabo E.; Paccaud F.M.; Padez C.; Pahomova E.; Pajak A.; Palli D.; Palmieri L.; Pan W-H.; Panda-Jonas S.; Panza F.; Papandreou D.; Park S-W.; Parnell W.R.; Parsaeian M.; Patel N.D.; Pecin I.; Pednekar M.S.; Peer N.; Peeters P.H.; Peixoto S.V.; Peltonen M.; Pereira A.C.; Peters A.; Petersmann A.; Petkeviciene J.; Peykari N.; Pham S.T.; Pigeot I.; Pikhart H.; Pilav A.; Pilotto L.; Pitakaka F.; Piwonska A.; Plans-Rubi\u00f3 P.; Pola\u0161ek O.; Porta M.; Portegies M.L.P.; Pourshams A.; Poustchi H.; Pradeepa R.; Prashant M.; Price J.F.; Puder J.J.; Puiu M.; Punab M.; Qasrawi R.F.; Qorbani M.; Bao T.Q.; Radic I.; Radisauskas R.; Rahman M.; Raitakari O.; Raj M.; Ramachandra Rao S.; Ramachandran A.; Ramos E.; Rampal L.; Rampal S.; Rangel Reina D.A.; Redon J.; Reganit P.F.M.; Ribeiro R.; Riboli E.; Rigo F.; Rinke de Wit T.F.; Ritti-Dias R.M.; Robinson S.M.; Robitaille C.; Rodr\u00edguez-Artalejo F.; del Cristo Rodriguez-Perez M.; Rodr\u00edguez-Villamizar L.A.; Rojas-Martinez R.; Romaguera D.; Ronkainen K.; Rosengren A.; Roy J.G.R.; Rubinstein A.; Sandra Ruiz-Betancourt B.; Rutkowski M.; Sabanayagam C.; Sachdev H.S.; Saidi O.; Sakarya S.; Salanave B.; Salazar Martinez E.; Salmer\u00f3n D.; Salomaa V.; Salonen J.T.; Salvetti M.; S\u00e1nchez-Abanto J.; Sans S.; Santos D.A.; Santos I.S.; Nunes dos Santos R.; Santos R.; Saramies J.L.; Sardinha L.B.; Sarganas G.; Sarrafzadegan N.; Saum K-U.; Savva S.; Scazufca M.; Schargrodsky H.; Schipf S.; Schmidt C.O.; Sch\u00f6ttker B.; Schultsz C.; Schutte A.E.; Sein A.A.; Sen A.; Senbanjo I.O.; Sepanlou S.G.; Sharma S.K.; Shaw J.E.; Shibuya K.; Shin D.W.; Shin Y.; Si-Ramlee K.; Siantar R.; Sibai A.M.; Santos Silva D.A.; Simon M.; Simons J.; Simons L.A.; Sj\u00f6str\u00f6m M.; Skovbjerg S.; Slowikowska-Hilczer J.; Slusarczyk P.; Smeeth L.; Smith M.C.; Snijder M.B.; So H-K.; Sobngwi E.; S\u00f6derberg S.; Solfrizzi V.; Sonestedt E.; Song Y.; S\u00f8rensen T.I.A.; Soric M.; J\u00e9rome C.S.; Soumare A.; Staessen J.A.; Starc G.; Stathopoulou M.G.; Stavreski B.; Steene-Johannessen J.; Stehle P.; Stein A.D.; Stergiou G.S.; Stessman J.; Stieber J.; St\u00f6ckl D.; Stocks T.; Stokwiszewski J.; Stronks K.; Strufaldi M.W.; Sun C-A.; Sundstr\u00f6m J.; Sung Y-T.; Suriyawongpaisal P.; Sy R.G.; Shyong Tai E.; Tammesoo M-L.; Tamosiunas A.; Tan E.J.; Tang X.; Tanser F.; Tao Y.; Tarawneh M.R.; Tarqui-Mamani C.B.; Tautu O-F.; Taylor A.; Theobald H.; Theodoridis X.; Thijs L.; Thuesen B.H.; Tjonneland A.; Tolonen H.K.; Tolstrup J.S.; Topbas M.; Top\u00f3r-Madry R.; Tormo M.J.; Torrent M.; Traissac P.; Trichopoulos D.; Trichopoulou A.; Trinh O.T.H.; Trivedi A.; Tshepo L.; Tulloch-Reid M.K.; Tullu F.; Tuomainen T-P.; Tuomilehto J.; Turley M.L.; Tynelius P.; Tzourio C.; Ueda P.; Ugel E.E.; Ulmer H.; Uusitalo H.M.T.; Valdivia G.; Valvi D.; van der Schouw Y.T.; Van Herck K.; Van Minh H.; van Rossem L.; Van Schoor N.M.; van Valkengoed I.G.M.; Vanderschueren D.; Vanuzzo D.; Vatten L.; Vega T.; Velasquez-Melendez G.; Veronesi G.; Monique Verschuren W.M.; Verstraeten R.; Victora C.G.; Viet L.; Viikari-Juntura E.; Vineis P.; Vioque J.; Virtanen J.K.; Visvikis-Siest S.; Viswanathan B.; Vlasoff T.; Vollenweider P.; Voutilainen S.; Wade A.N.; Wagner A.; Walton J.; Wan Bebakar W.M.; Wan Mohamud W.N.; Wanderley R.S.; Wang M-D.; Wang Q.; Wang Y.X.; Wang Y-W.; Wannamethee S.G.; Wareham N.; Wedderkopp N.; Weerasekera D.; Whincup P.H.; Widhalm K.; Widyahening I.S.; Wiecek A.; Wijga A.H.; Wilks R.J.; Willeit J.; Willeit P.; Williams E.A.; Wilsgaard T.; Wojtyniak B.; Wong-McClure R.A.; Wong J.Y.Y.; Wong T.Y.; Woo J.; Woodward M.; Giwercman Wu A.; Wu F.C.; Wu S.; Xu H.; Yan W.; Yang X.; Ye X.; Yiallouros P.K.; Yoshihara A.; Younger-Coleman N.O.; Yusoff A.F.; Zainuddin A.A.; Zambon S.; Zampelas A.; Zdrojewski T.; Zeng Y.; Zhao D.; Zhao W.; Zheng W.; Zheng Y.; Zhu D.; Zhussupov B.; Zimmermann E.; Cisneros J.Z.; Contributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: A pooled analysis of 1018 population-based measurement studies with 88.6 million participants. Int J Epidemiol 2018,47(3),872-883i","journal-title":"Int J Epidemiol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1093\/rheumatology\/kew039","volume":"55","author":"van Breukelen-van der Stoep D.F.","year":"2016","unstructured":"van Breukelen-van der Stoep D.F.; van Zeben D.; Klop B.; van de Geijn G.J.M.; Janssen H.J.W.; van der Meulen N.; De Vries M.A.; Hazes M.; Birnie E.; Castro Cabezas M.; Marked underdiagnosis and undertreatment of hypertension and hypercholesterolaemia in rheumatoid arthritis. Rheumatology (Oxford) 2016,55(7),1210-1216","journal-title":"Rheumatology (Oxford)"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1524-6175.2005.04806.x","volume":"7","author":"Materson B.J.","year":"2005","unstructured":"Materson B.J.; Expanding the definition and classification of hypertension. J Clin Hypertens (Greenwich) 2005,7(9),540-541","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ccl.2016.12.006","volume":"35","author":"Ruzicka M.","year":"2017","unstructured":"Ruzicka M.; Kucharski S.E.; Hiremath S.; Balancing overscreening and underdiagnosis in secondary hypertension. Cardiol Clin 2017,35(2),247-254","journal-title":"Cardiol Clin"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S0140-6736(14)61468-9","volume":"386","author":"Poulter N.R.","year":"2015","unstructured":"Poulter N.R.; Prabhakaran D.; Caulfield M.; Hypertension. Lancet 2015,386(9995),801-812","journal-title":"Lancet"},{"key":"ref=8","first-page":"62","volume":"1","author":"Mohamed F.","year":"1872","unstructured":"Mohamed F.; The physiology and clinical use of the sphygmograph. Med Times Gazette 1872,1,62","journal-title":"Med Times Gazette"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1161\/01.HYP.19.2.212","volume":"19","author":"O\u2019Rourke M.F.","year":"1992","unstructured":"O\u2019Rourke M.F.; Frederick akbar mahomed. Hypertension 1992,19(2),212-217","journal-title":"Hypertension"},{"key":"ref=10","first-page":"365","volume":"11","author":"Korotkoff N.","year":"1905","unstructured":"Korotkoff N.; On methods of studying blood pressure. Izv Venno-Med Akad 1905,11,365","journal-title":"Izv Venno-Med Akad"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/clc.4960200520","volume":"20","author":"Mancia G.","year":"1997","unstructured":"Mancia G.; Scipione riva-rocci. Clin Cardiol 1997,20(5),503-504","journal-title":"Clin Cardiol"},{"key":"ref=12","first-page":"981","volume":"47","author":"Riva-Rocci S.","year":"1896","unstructured":"Riva-Rocci S.; Un nuovo sfigmomanometro. Gazzetta medica di Torino 1896,47,981-1001","journal-title":"Gazzetta medica di Torino"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"561","DOI":"10.7326\/0003-4819-83-4-561","volume":"83","author":"Segall H.N.","year":"1975","unstructured":"Segall H.N.; How Korotkoff, the surgeon, discovered the auscultatory method of measuring arterial pressure. Ann Intern Med 1975,83(4),561-562","journal-title":"Ann Intern Med"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1161\/hy1201.101214","volume":"38","author":"Basso N.","year":"2001","unstructured":"Basso N.; Terragno N.A.; History about the discovery of the renin-angiotensin system. Hypertension 2001,38(6),1246-1249","journal-title":"Hypertension"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1748-1716.1898.tb00272.x","volume":"8","author":"Tigerstedt R.","year":"1898","unstructured":"Tigerstedt R.; Bergman P.Q.; Niere und Kreislauf. Skand Arch Physiol 1898,8(1),223-271","journal-title":"Skand Arch Physiol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"F167","DOI":"10.1152\/ajprenal.00503.2014","volume":"308","author":"Johnson R.J.","year":"2015","unstructured":"Johnson R.J.; Lanaspa M.A.; Gabriela S\u00e1nchez-Lozada L.; Rodriguez-Iturbe B.; The discovery of hypertension: Evolving views on the role of the kidneys, and current hot topics. Am J Physiol Renal Physiol 2015,308(3),F167-F178","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref=17","first-page":"959","volume":"80","author":"Cook H.W.","year":"1911","unstructured":"Cook H.W.; Blood pressure in prognosis. Med Rec 1911,80,959-968","journal-title":"Med Rec"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1084\/jem.59.3.347","volume":"59","author":"Goldblatt H.","year":"1934","unstructured":"Goldblatt H.; Lynch J.; Hanzal R.F.; Summerville W.W.; Studies on experimental hypertension: I. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med 1934,59(3),347-379","journal-title":"J Exp Med"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1126\/science.127.3292.242.b","volume":"127","author":"Braun-Menendez E.","year":"1958","unstructured":"Braun-Menendez E.; Page I.H.; Suggested revision of nomenclature\u2014angiotensin. Science 1958,127(3292),242","journal-title":"Science"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1126\/science.92.2398.554","volume":"92","author":"Fasciolo J.C.","year":"1940","unstructured":"Fasciolo J.C.; Leloir L.F.; Mu\u00f1oz J.M.; Braun-Menendez E.; On the specificity of renin. Science 1940,92(2398),554-555","journal-title":"Science"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1113\/jphysiol.1938.sp003680","volume":"94","author":"Fasciolo J.C.","year":"1938","unstructured":"Fasciolo J.C.; Houssay B.A.; Taquini A.C.; The blood-pressure raising secretion of the ischaemic kidney. J Physiol 1938,94(3),281-293","journal-title":"J Physiol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.7326\/0003-4819-11-1-69","volume":"11","author":"Goldblatt H.","year":"1937","unstructured":"Goldblatt H.; Studies on experimental hypertension: V. The pathogenesis of experimental hypertension due to renal ischemia. Ann Intern Med 1937,11(1),69-103","journal-title":"Ann Intern Med"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3181\/00379727-35-8877C","volume":"35","author":"Page I.H.","year":"1936","unstructured":"Page I.H.; Vaso-pressor action of extracts of plasma of normal dogs and dogs with experimentally produced hypertension. Exp Biol Med (Maywood) 1936,35(1),112-116","journal-title":"Exp Biol Med (Maywood)"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fcvm.2016.00003","volume":"3","author":"Saklayen M.G.","year":"2016","unstructured":"Saklayen M.G.; Deshpande N.V.; Timeline of history of hypertension treatment. Front Cardiovasc Med 2016,3,3","journal-title":"Front Cardiovasc Med"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/S0041-0101(97)00008-1","volume":"35","author":"Hawgood B.J.","year":"1997","unstructured":"Hawgood B.J.; Maur\u00edcio Rocha E Silva MD: Snake venom, bradykinin and the rise of autopharmacology. Toxicon 1997,35(11),1569-1580","journal-title":"Toxicon"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1152\/ajplegacy.1949.156.2.261","volume":"156","author":"e Silva M.R.","year":"1949","unstructured":"e Silva M.R.; Beraldo W.T.; Rosenfeld G.; Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin. Am J Physiol 1949,156(2),261-273","journal-title":"Am J Physiol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1084\/jem.103.3.295","volume":"103","author":"Skeggs L.T.","year":"1956","unstructured":"Skeggs L.T.; Kahn J.R.; Shumway N.P.; The preparation and function of the hypertensin-converting enzyme. J Exp Med 1956,103(3),295-299","journal-title":"J Exp Med"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1001\/jama.1958.02990020025004","volume":"166","author":"Freis E.D.","year":"1958","unstructured":"Freis E.D.; Wanko A.; Wilson I.M.; Parrish A.E.; Treatment of essential hypertension with chlorothiazide (diuril); its use alone and combined with other antihypertensive agents. J Am Med Assoc 1958,166(2),137-140","journal-title":"J Am Med Assoc"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1136\/bmj.1.5172.515","volume":"1","author":"Smirk H.","year":"1960","unstructured":"Smirk H.; McQueen E.G.; Morrison R.B.I.; Chlorothiazide and hydrochlorothiazide in management of hypertension. BMJ 1960,1(5172),515-518","journal-title":"BMJ"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/S0140-6736(63)91443-0","volume":"281","author":"Borst J.G.G.","year":"1963","unstructured":"Borst J.G.G.; Borst-de Geus A.; Hypertension explained by Starling\u2019s theory of circulatory homoeostasis. Lancet 1963,281(7283),677-682","journal-title":"Lancet"},{"key":"ref=31","first-page":"811","volume":"45","author":"Guyton A.C.","year":"1969","unstructured":"Guyton A.C.; Coleman T.G.; Fourcade J.C.; Navar L.G.; Physiologic control of arterial pressure. Bull N Y Acad Med 1969,45(9),811-830","journal-title":"Bull N Y Acad Med"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0002-9149(71)90428-0","volume":"27","author":"Kannel W.B.","year":"1971","unstructured":"Kannel W.B.; Gordon T.; Schwartz M.J.; Systolic versus diastolic blood pressure and risk of coronary heart disease. Am J Cardiol 1971,27(4),335-346","journal-title":"Am J Cardiol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1042\/cs0470435","volume":"47","author":"Bianchi G.","year":"1974","unstructured":"Bianchi G.; Fox U.; Di Francesco G.F.; Giovanetti A.M.; Pagetti D.; Blood pressure changes produced by kidney cross-transplantation between spontaneously hypertensive rats and normotensive rats. Clin Sci Mol Med 1974,47(5),435-448","journal-title":"Clin Sci Mol Med"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/ajh\/1.4.335","volume":"1","author":"Brenner B.M.","year":"1988","unstructured":"Brenner B.M.; Garcia D.L.; Anderson S.; Glomeruli and blood pressure. Less of one, more the other? Am J Hypertens 1988,1(4 Pt 1),335-347","journal-title":"Am J Hypertens"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/ki.1982.32","volume":"21","author":"Campese V.M.","year":"1982","unstructured":"Campese V.M.; Romoff M.S.; Levitan D.; Saglikes Y.; Friedler R.M.; Massry S.G.; Abnormal relationship between sodium intake and sympathetic nervous system activity in salt-sensitive patients with essential hypertension. Kidney Int 1982,21(2),371-378","journal-title":"Kidney Int"},{"key":"ref=36","first-page":"81","volume":"2","author":"DiBona G.F.","year":"1995","unstructured":"DiBona G.F.; Renal neural mechanisms in salt-sensitive hypertension. Blood Press Suppl 1995,2,81-87","journal-title":"Blood Press Suppl"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1161\/01.HYP.11.4.312","volume":"11","author":"Gill J.R.","year":"1988","unstructured":"Gill J.R.; G\u00fcllner G.; Lake C.R.; Lakatua D.J.; Lan G.; Plasma and urinary catecholamines in salt-sensitive idiopathic hypertension. Hypertension 1988,11(4),312-319","journal-title":"Hypertension"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/0002-9343(72)90050-2","volume":"52","author":"Guyton A.C.","year":"1972","unstructured":"Guyton A.C.; Coleman T.G.; Cowley A.W.; Scheel K.W.; Manning R.D.; Norman R.A.; Arterial pressure regulation. Am J Med 1972,52(5),584-594","journal-title":"Am J Med"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/ajh.2011.171","volume":"24","author":"Laragh J.H.","year":"2011","unstructured":"Laragh J.H.; Sealey J.E.; The plasma renin test reveals the contribution of body sodium-volume content (V) and renin-angiotensin (R) vasoconstriction to long-term blood pressure. Am J Hypertens 2011,24(11),1164-1180","journal-title":"Am J Hypertens"},{"key":"ref=40","first-page":"71","volume":"100","author":"Lifton R.P.","year":"2004-2005","unstructured":"Lifton R.P.; Genetic dissection of human blood pressure variation: Common pathways from rare phenotypes. Harvey Lect 2004-2005,100,71-101","journal-title":"Harvey Lect"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1053\/j.ajkd.2007.05.025","volume":"50","author":"Rodriguez-Iturbe B.","year":"2007","unstructured":"Rodriguez-Iturbe B.; Romero F.; Johnson R.J.; Pathophysiological mechanisms of salt-dependent hypertension. Am J Kidney Dis 2007,50(4),655-672","journal-title":"Am J Kidney Dis"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/ajh\/3.7.583","volume":"3","author":"Sommers S.","year":"1990","unstructured":"Sommers S.; Melamed J.; Renal pathology of essential hypertension. Am J Hypertens 1990,3(7),583-587","journal-title":"Am J Hypertens"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"R913","DOI":"10.1152\/ajpregu.00250.2005","volume":"289","author":"Wilcox C.S.","year":"2005","unstructured":"Wilcox C.S.; Oxidative stress and nitric oxide deficiency in the kidney: A critical link to hypertension? Am J Physiol Regul Integr Comp Physiol 2005,289(4),R913-R935","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","volume":"366","author":"Dahl\u00f6f B.","year":"2005","unstructured":"Dahl\u00f6f B.; Sever P.S.; Poulter N.R.; Wedel H.; Beevers D.G.; Caulfield M.; Collins R.; Kjeldsen S.E.; Kristinsson A.; McInnes G.T.; Mehlsen J.; Nieminen M.; O\u2019Brien E.; \u00d6stergren J.; Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): A multicentre randomised controlled trial. Lancet 2005,366(9489),895-906","journal-title":"Lancet"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","volume":"288","author":"Officers A.","year":"2002","unstructured":"Officers A.; Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002,288(23),2981-2997","journal-title":"JAMA"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.phrs.2017.07.026","volume":"124","author":"Laurent S.","year":"2017","unstructured":"Laurent S.; Antihypertensive drugs. Pharmacol Res 2017,124,116-125","journal-title":"Pharmacol Res"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1136\/bmj.298.6687.1552","volume":"298","author":"Staessen J.","year":"1989","unstructured":"Staessen J.; Bulpitt C.; Clement D.; De Leeuw P.; Fagard R.; Fletcher A.; Forette F.; Leonetti G.; Nissinen A.; O\u2019Malley K.; Relation between mortality and treated blood pressure in elderly patients with hypertension: Report of the European Working Party on High Blood Pressure in the Elderly. BMJ 1989,298(6687),1552-1556","journal-title":"BMJ"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1056\/NEJM199704173361601","volume":"336","author":"Appel L.J.","year":"1997","unstructured":"Appel L.J.; Moore T.J.; Obarzanek E.; Vollmer W.M.; Svetkey L.P.; Sacks F.M.; Bray G.A.; Vogt T.M.; Cutler J.A.; Windhauser M.M.; Lin P.H.; Karanja N.; Simons-Morton D.; McCullough M.; Swain J.; Steele P.; Evans M.A.; Miller E.R.; Harsha D.W.; A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 1997,336(16),1117-1124","journal-title":"N Engl J Med"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/S0140-6736(97)02264-2","volume":"350","author":"Cappuccio F.P.","year":"1997","unstructured":"Cappuccio F.P.; Markandu N.D.; Carney C.; Sagnella G.A.; MacGregor G.A.; Double-blind randomised trial of modest salt restriction in older people. Lancet 1997,350(9081),850-854","journal-title":"Lancet"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1056\/NEJMc1306659","volume":"369","author":"Opie L.H.","year":"2013","unstructured":"Opie L.H.; Mediterranean diet for primary prevention of cardiovascular disease. N Engl J Med 2013,369(7),672-677","journal-title":"N Engl J Med"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1161\/HYPERTENSIONAHA.113.01274","volume":"63","author":"Santos R.A.","year":"2014","unstructured":"Santos R.A.; Angiotensin-(1\u20137). Hypertension 2014,63(6),1138-1147","journal-title":"Hypertension"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10544-014-9911-z","volume":"17","author":"Rolim T.","year":"2015","unstructured":"Rolim T.; Cancino J.; Zucolotto V.; A nanostructured genosensor for the early diagnosis of systemic arterial hypertension. Biomed Microdevices 2015,17(1),3","journal-title":"Biomed Microdevices"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s11906-014-0483-3","volume":"16","author":"Cuffee Y.","year":"2014","unstructured":"Cuffee Y.; Ogedegbe C.; Williams N.J.; Ogedegbe G.; Schoenthaler A.; Psychosocial risk factors for hypertension: An update of the literature. Curr Hypertens Rep 2014,16(10),483","journal-title":"Curr Hypertens Rep"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.cca.2017.02.017","volume":"468","author":"Liu K.","year":"2017","unstructured":"Liu K.; Tang Q.; Zhu X.; Yang X.; IL-37 increased in patients with acute coronary syndrome and associated with a worse clinical outcome after ST-segment elevation acute myocardial infarction. Clin Chim Acta 2017,468,140-144","journal-title":"Clin Chim Acta"},{"key":"ref=55","first-page":"1121","volume":"11","author":"Pan Y.","year":"2015","unstructured":"Pan Y.; Cai W.; Cheng Q.; Dong W.; An T.; Yan J.; Association between anxiety and hypertension: A systematic review and meta-analysis of epidemiological studies. Neuropsychiatr Dis Treat 2015,11,1121-1130","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref=56","first-page":"10","volume":"18","author":"Rubio-Guerra A.F.","year":"2013","unstructured":"Rubio-Guerra A.F.; Rodriguez-Lopez L.; Vargas-Ayala G.; Huerta-Ramirez S.; Serna D.C.; Lozano-Nuevo J.J.; Depression increases the risk for uncontrolled hypertension. Exp Clin Cardiol 2013,18(1),10-12","journal-title":"Exp Clin Cardiol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1590\/S1807-59322005000300010","volume":"60","author":"Scalco A.Z.","year":"2005","unstructured":"Scalco A.Z.; Scalco M.Z.; Azul J.B.S.; Neto F.L.; Hypertension and depression. Clinics (S\u00e3o Paulo) 2005,60(3),241-250","journal-title":"Clinics (S\u00e3o Paulo)"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11906-009-0084-8","volume":"12","author":"Spruill T.M.","year":"2010","unstructured":"Spruill T.M.; Chronic psychosocial stress and hypertension. Curr Hypertens Rep 2010,12(1),10-16","journal-title":"Curr Hypertens Rep"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"S148","DOI":"10.1093\/sleep\/16.suppl_8.S148","volume":"16","author":"Worsnop C.J.","year":"1993","unstructured":"Worsnop C.J.; Pierce R.J.; Naughton M.; Systemic hypertension and obstructive sleep apnea. Sleep 1993,16(8),S148-S149","journal-title":"Sleep"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1016\/j.ijcard.2012.11.037","volume":"167","author":"Baguet J.P.","year":"2013","unstructured":"Baguet J.P.; Boutin I.; Barone-Rochette G.; Levy P.; Tamisier R.; Pierre H.; Boggetto-Graham L.; P\u00e9pin J.L.; Hypertension diagnosis in obstructive sleep apnea: Self or 24-hour ambulatory blood pressure monitoring? Int J Cardiol 2013,167(5),2346-2347","journal-title":"Int J Cardiol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"S4189","DOI":"10.21037\/jtd.2018.12.56","volume":"10","author":"Sarkar P.","year":"2018","unstructured":"Sarkar P.; Mukherjee S.; Chai-Coetzer C.L.; McEvoy R.D.; The epidemiology of obstructive sleep apnoea and cardiovascular disease. J Thorac Dis 2018,10(S34),S4189-S4200","journal-title":"J Thorac Dis"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1161\/CIRCRESAHA.116.305697","volume":"116","author":"Hall J.E.","year":"2015","unstructured":"Hall J.E.; do Carmo J.M.; da Silva A.A.; Wang Z.; Hall M.E.; Obesity-induced hypertension. Circ Res 2015,116(6),991-1006","journal-title":"Circ Res"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/hr.2017.75","volume":"40","author":"Leggio M.","year":"2017","unstructured":"Leggio M.; Lombardi M.; Caldarone E.; Severi P.; D\u2019Emidio S.; Armeni M.; Bravi V.; Bendini M.G.; Mazza A.; The relationship between obesity and hypertension: An updated comprehensive overview on vicious twins. Hypertens Res 2017,40(12),947-963","journal-title":"Hypertens Res"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1161\/01.HYP.0000032940.33466.12","volume":"40","author":"Sorof J.","year":"2002","unstructured":"Sorof J.; Daniels S.; Obesity hypertension in children: A problem of epidemic proportions. Hypertension 2002,40(4),441-447","journal-title":"Hypertension"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.2337\/dci17-0026","volume":"40","author":"de Boer I.H.","year":"2017","unstructured":"de Boer I.H.; Bangalore S.; Benetos A.; Davis A.M.; Michos E.D.; Muntner P.; Rossing P.; Zoungas S.; Bakris G.; Diabetes and hypertension: A position statement by the american diabetes association. Diabetes Care 2017,40(9),1273-1284","journal-title":"Diabetes Care"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S0140-6736(12)60987-8","volume":"380","author":"Ferrannini E.","year":"2012","unstructured":"Ferrannini E.; Cushman W.C.; Diabetes and hypertension: The bad companions. Lancet 2012,380(9841),601-610","journal-title":"Lancet"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41440-018-0034-4","volume":"41","author":"Ohishi M.","year":"2018","unstructured":"Ohishi M.; Hypertension with diabetes mellitus: Physiology and pathology. Hypertens Res 2018,41(6),389-393","journal-title":"Hypertens Res"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.1038\/s41467-020-18538-x","volume":"11","author":"Oh J.","year":"2020","unstructured":"Oh J.; Matkovich S.J.; Riek A.E.; Bindom S.M.; Shao J.S.; Head R.D.; Barve R.A.; Sands M.S.; Carmeliet G.; Osei-Owusu P.; Knutsen R.H.; Zhang H.; Blumer K.J.; Nichols C.G.; Mecham R.P.; Bald\u00e1n \u00c1.; Benitez B.A.; Sequeira-Lopez M.L.; Gomez R.A.; Bernal-Mizrachi C.; Macrophage secretion of miR-106b-5p causes renin-dependent hypertension. Nat Commun 2020,11(1),4798","journal-title":"Nat Commun"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"118156","DOI":"10.1016\/j.lfs.2020.118156","volume":"258","author":"Zhong X.","year":"2020","unstructured":"Zhong X.; Ma Z.; Su Y.; Li Z.; Liao Y.; Pan X.; Zang L.; Zhou S.; Flavin adenine dinucleotide ameliorates hypertensive vascular remodeling via activating short chain acyl-CoA dehydrogenase. Life Sci 2020,258,118156","journal-title":"Life Sci"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1080\/14779072.2018.1540301","volume":"16","author":"Saxena T.","year":"2018","unstructured":"Saxena T.; Ali A.O.; Saxena M.; Pathophysiology of essential hypertension: An update. Expert Rev Cardiovasc Ther 2018,16(12),879-887","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1002\/cphy.c110058","volume":"2","author":"Hall J.E.","year":"2012","unstructured":"Hall J.E.; Granger J.P.; do Carmo J.M.; da Silva A.A.; Dubinion J.; George E.; Hamza S.; Speed J.; Hall M.E.; Hypertension: Physiology and pathophysiology. Compr Physiol 2012,2(4),2393-2442","journal-title":"Compr Physiol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1096\/fj.15-277046","volume":"30","author":"Roy A.","year":"2016","unstructured":"Roy A.; Dakroub M.; Tezini G.C.S.V.; Liu Y.; Guatimosim S.; Feng Q.; Salgado H.C.; Prado V.F.; Prado M.A.M.; Gros R.; Cardiac acetylcholine inhibits ventricular remodeling and dysfunction under pathologic conditions. FASEB J 2016,30(2),688-701","journal-title":"FASEB J"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2119\/molmed.2014.00125","volume":"20","author":"Roy A.","year":"2014","unstructured":"Roy A.; Guatimosim S.; Prado V.F.; Gros R.; Prado M.A.M.; Cholinergic activity as a new target in diseases of the heart. Mol Med 2014,20(1),527-537","journal-title":"Mol Med"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"H655","DOI":"10.1152\/ajpheart.00114.2015","volume":"309","author":"Durand M.T.","year":"2015","unstructured":"Durand M.T.; Becari C.; Tezini G.C.S.V.; Fazan R.; Oliveira M.; Guatimosim S.; Prado V.F.; Prado M.A.M.; Salgado H.C.; Autonomic cardiocirculatory control in mice with reduced expression of the vesicular acetylcholine transporter. Am J Physiol Heart Circ Physiol 2015,309(4),H655-H662","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s10286-018-0541-z","volume":"28","author":"Mann S.J.","year":"2018","unstructured":"Mann S.J.; Neurogenic hypertension: Pathophysiology, diagnosis and management. Clin Auton Res 2018,28(4),363-374","journal-title":"Clin Auton Res"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1161\/HYPERTENSIONAHA.114.04893","volume":"66","author":"de Almeida P.W.M.","year":"2015","unstructured":"de Almeida P.W.M.; Melo M.B.; Lima R.F.; Gavioli M.; Santiago N.M.; Greco L.; Jesus I.C.G.; Nocchi E.; Parreira A.; Alves M.N.M.; Mitraud L.; Resende R.R.; Campagnole-Santos M.J.; dos Santos R.A.S.; Guatimosim S.; Beneficial effects of angiotensin-(1-7) against deoxycorticosterone acetate-induced diastolic dysfunction occur independently of changes in blood pressure. Hypertension 2015,66(2),389-395","journal-title":"Hypertension"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"172488","DOI":"10.1016\/j.ejphar.2019.172488","volume":"859","author":"Souza D.S.","year":"2019","unstructured":"Souza D.S.; Menezes-Filho J.E.R.; Santos-Miranda A.; Jesus I.C.G.; Silva Neto J.A.; Guatimosim S.; Cruz J.S.; Vasconcelos C.M.L.; Calcium overload-induced arrhythmia is suppressed by farnesol in rat heart. Eur J Pharmacol 2019,859,172488","journal-title":"Eur J Pharmacol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"C310","DOI":"10.1152\/ajpcell.00060.2017","volume":"314","author":"Goncalves G.K.","year":"2018","unstructured":"Goncalves G.K.; Scalzo S.; Alves A.P.; Agero U.; Guatimosim S.; Reis A.M.; Neonatal cardiomyocyte hypertrophy induced by endothelin-1 is blocked by estradiol acting on GPER. Am J Physiol Cell Physiol 2018,314(3),C310-C322","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"R1089","DOI":"10.1152\/ajpregu.00373.2009","volume":"298","author":"Crowley S.D.","year":"2010","unstructured":"Crowley S.D.; Song Y.S.; Lin E.E.; Griffiths R.; Kim H.S.; Ruiz P.; Lymphocyte responses exacerbate angiotensin II-dependent hypertension. Am J Physiol Regul Integr Comp Physiol 2010,298(4),R1089-R1097","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1084\/jem.20171274","volume":"215","author":"Hulsmans M.","year":"2018","unstructured":"Hulsmans M.; Sager H.B.; Roh J.D.; Valero-Mu\u00f1oz M.; Houstis N.E.; Iwamoto Y.; Sun Y.; Wilson R.M.; Wojtkiewicz G.; Tricot B.; Osborne M.T.; Hung J.; Vinegoni C.; Naxerova K.; Sosnovik D.E.; Zile M.R.; Bradshaw A.D.; Liao R.; Tawakol A.; Weissleder R.; Rosenzweig A.; Swirski F.K.; Sam F.; Nahrendorf M.; Cardiac macrophages promote diastolic dysfunction. J Exp Med 2018,215(2),423-440","journal-title":"J Exp Med"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1161\/01.RES.0000182677.89816.38","volume":"97","author":"Shagdarsuren E.","year":"2005","unstructured":"Shagdarsuren E.; Wellner M.; Braesen J.H.; Park J.K.; Fiebeler A.; Henke N.; Dechend R.; Gratze P.; Luft F.C.; Muller D.N.; Complement activation in angiotensin II-induced organ damage. Circ Res 2005,97(7),716-724","journal-title":"Circ Res"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41590-021-00886-5","volume":"22","author":"Sharma B.R.","year":"2021","unstructured":"Sharma B.R.; Kanneganti T.D.; NLRP3 inflammasome in cancer and metabolic diseases. Nat Immunol 2021,22(5),550-559","journal-title":"Nat Immunol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.3390\/ijms22031064","volume":"22","author":"De Miguel C.","year":"2021","unstructured":"De Miguel C.; Pelegr\u00edn P.; Baroja-Mazo A.; Cuevas S.; Emerging role of the inflammasome and pyroptosis in hypertension. Int J Mol Sci 2021,22(3),1064","journal-title":"Int J Mol Sci"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.cyto.2018.02.007","volume":"105","author":"Rom\u00e3o-Veiga M.","year":"2018","unstructured":"Rom\u00e3o-Veiga M.; Matias M.L.; Ribeiro V.R.; Nunes P.R.; M Borges V.T.; Pera\u00e7oli J.C.; Pera\u00e7oli M.T.S.; Induction of systemic inflammation by hyaluronan and hsp70 in women with pre-eclampsia. Cytokine 2018,105,23-31","journal-title":"Cytokine"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"5589","DOI":"10.1111\/bph.12876","volume":"171","author":"Krishnan S.M.","year":"2014","unstructured":"Krishnan S.M.; Sobey C.G.; Latz E.; Mansell A.; Drummond G.R.;  -1\u03b2 and  -18: Inflammatory markers or mediators of hypertension? Br J Pharmacol 2014,171(24),5589-5602","journal-title":"Br J Pharmacol"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1161\/01.ATV.0000168417.52486.56","volume":"25","author":"Yamagami H.","year":"2005","unstructured":"Yamagami H.; Kitagawa K.; Hoshi T.; Furukado S.; Hougaku H.; Nagai Y.; Hori M.; Associations of serum IL-18 levels with carotid intima-media thickness. Arterioscler Thromb Vasc Biol 2005,25(7),1458-1462","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/jcmm.13333","volume":"22","author":"Ke B.","year":"2018","unstructured":"Ke B.; Shen W.; Fang X.; Wu Q.; The NLPR3 inflammasome and obesity-related kidney disease. J Cell Mol Med 2018,22(1),16-24","journal-title":"J Cell Mol Med"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1159\/000486061","volume":"44","author":"Ren X.S.","year":"2017","unstructured":"Ren X.S.; Tong Y.; Ling L.; Chen D.; Sun H.J.; Zhou H.; Qi X.H.; Chen Q.; Li Y.H.; Kang Y.M.; Zhu G.Q.; NLRP3 gene deletion attenuates angiotensin II-induced phenotypic transformation of vascular smooth muscle cells and vascular remodeling. Cell Physiol Biochem 2017,44(6),2269-2280","journal-title":"Cell Physiol Biochem"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s12015-019-09888-1","volume":"15","author":"Ratajczak M.Z.","year":"2019","unstructured":"Ratajczak M.Z.; Mack A.; Bujko K.; Domingues A.; Pedziwiatr D.; Kucia M.; Ratajczak J.; Ulrich H.; Kucharska-Mazur J.; Samochowiec J.; ATP-Nlrp3 inflammasome-complement cascade axis in sterile brain inflammation in psychiatric patients and its impact on stem cell trafficking. Stem Cell Rev 2019,15(4),497-505","journal-title":"Stem Cell Rev"},{"key":"ref=90","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/s41380-020-00965-3","volume":"26","author":"Ribeiro D.E.","year":"2021","unstructured":"Ribeiro D.E.; Oliveira-Giacomelli \u00c1.; Glaser T.; Arnaud-Sampaio V.F.; Andrejew R.; Dieckmann L.; Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology. Mol Psychiatry 2021,26,1044-1059","journal-title":"Mol Psychiatry"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1523-1755.2004.00717.x","volume":"66","author":"Vonend O.","year":"2004","unstructured":"Vonend O.; Turner C.M.; Chan C.M.; Loesch A.; Carmen Dell\u2019Anna G.; Srai K.S.; Burnstock G.; Unwin R.J.; Glomerular expression of the ATP-sensitive P2X7 receptor in diabetic and hypertensive rat models. Kidney Int 2004,66(1),157-166","journal-title":"Kidney Int"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/hr.2011.153","volume":"35","author":"Ji X.","year":"2012","unstructured":"Ji X.; Naito Y.; Hirokawa G.; Weng H.; Hiura Y.; Takahashi R.; Iwai N.; P2X7 receptor antagonism attenuates the hypertension and renal injury in Dahl salt-sensitive rats. Hypertens Res 2012,35(2),173-179","journal-title":"Hypertens Res"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"eaau6426","DOI":"10.1126\/sciimmunol.aau6426","volume":"4","author":"Zhao T.V.","year":"2019","unstructured":"Zhao T.V.; Li Y.; Liu X.; Xia S.; Shi P.; Li L.; Chen Z.; Yin C.; Eriguchi M.; Chen Y.; Bernstein E.A.; Giani J.F.; Bernstein K.E.; Shen X.Z.; ATP release drives heightened immune responses associated with hypertension. Sci Immunol 2019,4(36),eaau6426","journal-title":"Sci Immunol"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12979-015-0047-7","volume":"12","author":"Kunnas T.","year":"2015","unstructured":"Kunnas T.; M\u00e4\u00e4tt\u00e4 K.; Nikkari S.T.; NLR family pyrin domain containing 3 (NLRP3) inflammasome gene polymorphism rs7512998 (C>T) predicts aging-related increase of blood pressure, the TAMRISK study. Immun Ageing 2015,12(1),19","journal-title":"Immun Ageing"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/S0022-2143(97)90178-5","volume":"129","author":"Dalekos G.N.","year":"1997","unstructured":"Dalekos G.N.; Elisaf M.; Bairaktari E.; Tsolas O.; Siamopoulos K.C.; Increased serum levels of interleukin-1\u03b2 in the systemic circulation of patients with essential hypertension: Additional risk factor for atherogenesis in hypertensive patients? J Lab Clin Med 1997,129(3),300-308","journal-title":"J Lab Clin Med"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/00004872-200501000-00009","volume":"23","author":"Van Bortel L.M.","year":"2005","unstructured":"Van Bortel L.M.; What does intima-media thickness tell us? J Hypertens 2005,23(1),37-39","journal-title":"J Hypertens"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1084\/jem.20070657","volume":"204","author":"Guzik T.J.","year":"2007","unstructured":"Guzik T.J.; Hoch N.E.; Brown K.A.; McCann L.A.; Rahman A.; Dikalov S.; Goronzy J.; Weyand C.; Harrison D.G.; Role of the T cell in the genesis of angiotensin II\u2013induced hypertension and vascular dysfunction. J Exp Med 2007,204(10),2449-2460","journal-title":"J Exp Med"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1161\/HYPERTENSIONAHA.110.162941","volume":"57","author":"Barhoumi T.","year":"2011","unstructured":"Barhoumi T.; Kasal D.A.; Li M.W.; Shbat L.; Laurant P.; Neves M.F.; Paradis P.; Schiffrin E.L.; T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury. Hypertension 2011,57(3),469-476","journal-title":"Hypertension"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1161\/HYPERTENSIONAHA.115.05779","volume":"66","author":"Chan C.T.","year":"2015","unstructured":"Chan C.T.; Sobey C.G.; Lieu M.; Ferens D.; Kett M.M.; Diep H.; Kim H.A.; Krishnan S.M.; Lewis C.V.; Salimova E.; Tipping P.; Vinh A.; Samuel C.S.; Peter K.; Guzik T.J.; Kyaw T.S.; Toh B.H.; Bobik A.; Drummond G.R.; Obligatory role for B cells in the development of angiotensin II\u2013dependent hypertension. Hypertension 2015,66(5),1023-1033","journal-title":"Hypertension"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S0895-7061(01)02255-5","volume":"15","author":"Alexander B.T.","year":"2002","unstructured":"Alexander B.T.; Cockrell K.L.; Massey M.B.; Bennett W.A.; Granger J.P.; Tumor necrosis factor-induced hypertension in pregnant rats results in decreased renal neuronal nitric oxide synthase expression. Am J Hypertens 2002,15(2),170-175","journal-title":"Am J Hypertens"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1161\/01.HYP.0000113044.46326.98","volume":"43","author":"Orshal J.M.","year":"2004","unstructured":"Orshal J.M.; Khalil R.A.; Reduced endothelial NO-cGMP-mediated vascular relaxation and hypertension in IL-6-infused pregnant rats. Hypertension 2004,43(2),434-444","journal-title":"Hypertension"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1161\/01.HYP.0000175476.26719.36","volume":"46","author":"LaMarca B.B.D.","year":"2005","unstructured":"LaMarca B.B.D.; Bennett W.A.; Alexander B.T.; Cockrell K.; Granger J.P.; Hypertension produced by reductions in uterine perfusion in the pregnant rat: Role of tumor necrosis factor-alpha. Hypertension 2005,46(4),1022-1025","journal-title":"Hypertension"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s11886-008-0073-6","volume":"10","author":"Harrison D.G.","year":"2008","unstructured":"Harrison D.G.; Guzik T.J.; Goronzy J.; Weyand C.; Is hypertension an immunologic disease? Curr Cardiol Rep 2008,10(6),464-469","journal-title":"Curr Cardiol Rep"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.peptides.2012.05.005","volume":"36","author":"Da Silva S.L.","year":"2012","unstructured":"Da Silva S.L.; Dias-Junior C.A.; Baldasso P.A.; Damico D.C.S.; Carvalho B.M.A.; Garanto A.; Acosta G.; Oliveira E.; Albericio F.; Soares A.M.; Marangoni S.; Resende R.R.; Vascular effects and electrolyte homeostasis of the natriuretic peptide isolated from Crotalus oreganus abyssus (North American Grand Canyon rattlesnake) venom. Peptides 2012,36(2),206-212","journal-title":"Peptides"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10989-011-9254-z","volume":"17","author":"Da Silva S.L.","year":"2011","unstructured":"Da Silva S.L.; Almeida J.R.; Resende L.M.; Martins W.; Henriques F.A.F.A.; Baldasso P.A.; Soares A.M.; Taranto A.G.; Resende R.R.; Marangoni S.; Dias-Junior C.A.; Isolation and characterization of a natriuretic peptide from Crotalus oreganus abyssus (grand canyon rattlesnake) and its effects on systemic blood pressure and nitrite levels. Int J Pept Res Ther 2011,17(3),165-173","journal-title":"Int J Pept Res Ther"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1586\/14737159.3.5.525","volume":"3","author":"Naylor S.","year":"2003","unstructured":"Naylor S.; Biomarkers: Current perspectives and future prospects. Expert Rev Mol Diagn 2003,3(5),525-529","journal-title":"Expert Rev Mol Diagn"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/COH.0b013e32833ed177","volume":"5","author":"Strimbu K.","year":"2010","unstructured":"Strimbu K.; Tavel J.A.; What are biomarkers? Curr Opin HIV AIDS 2010,5(6),463-466","journal-title":"Curr Opin HIV AIDS"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1602\/neurorx.1.2.182","volume":"1","author":"Mayeux R.","year":"2004","unstructured":"Mayeux R.; Biomarkers: Potential uses and limitations. NeuroRx 2004,1(2),182-188","journal-title":"NeuroRx"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1878-5085-4-7","volume":"4","author":"Drucker E.","year":"2013","unstructured":"Drucker E.; Krapfenbauer K.; Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine. EPMA J 2013,4(1),7","journal-title":"EPMA J"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.3906\/sag-1912-197","volume":"50","author":"Ak\u00e7an R.","year":"2020","unstructured":"Ak\u00e7an R.; Ta\u015fteki\u0307n B.; Yildirim M.\u015e.; Aydogan H.C.; Sa\u011flam N.; Omics era in forensic medicine: Towards a new age. Turk J Med Sci 2020,50(5),1480-1490","journal-title":"Turk J Med Sci"},{"key":"ref=111","first-page":"1","author":"Vailati-Riboni M.","year":"2017","unstructured":"Vailati-Riboni M.; Palombo V.; Loor J.J.; What are omics sciences? Periparturient Diseases of Dairy Cows 2017,1-7","journal-title":"Periparturient Diseases of Dairy Cows"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.2215\/CJN.11531114","volume":"10","author":"Jablonski K.L.","year":"2015","unstructured":"Jablonski K.L.; Klawitter J.; Chonchol M.; Bassett C.J.; Racine M.L.; Seals D.R.; Effect of dietary sodium restriction on human urinary metabolomic profiles. Clin J Am Soc Nephrol 2015,10(7),1227-1234","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.cardfail.2015.10.003","volume":"21","author":"Mathew A.V.","year":"2015","unstructured":"Mathew A.V.; Seymour E.M.; Byun J.; Pennathur S.; Hummel S.L.; Altered metabolic profile with sodium-restricted dietary approaches to stop hypertension diet in hypertensive heart failure with preserved ejection fraction. J Card Fail 2015,21(12),963-967","journal-title":"J Card Fail"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"e96735","DOI":"10.1371\/journal.pone.0096735","volume":"9","author":"Kim M.","year":"2014","unstructured":"Kim M.; Jung S.; Kim S.Y.; Lee S.H.; Lee J.H.; Prehypertension-associated elevation in circulating lysophosphatidlycholines, Lp-PLA2 activity, and oxidative stress. PLoS One 2014,9(5),e96735","journal-title":"PLoS One"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1038\/s41598-017-02289-9","volume":"7","author":"Ameta K.","year":"2017","unstructured":"Ameta K.; Gupta A.; Kumar S.; Sethi R.; Kumar D.; Mahdi A.A.; Essential hypertension: A filtered serum based metabolomics study. Sci Rep 2017,7(1),2153","journal-title":"Sci Rep"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/hr.2010.205","volume":"34","author":"Derosa G.","year":"2011","unstructured":"Derosa G.; Maffioli P.; Ferrari I.; Palumbo I.; Randazzo S.; Fogari E.; D\u2019Angelo A.; Cicero A.F.G.; Different actions of losartan and ramipril on adipose tissue activity and vascular remodeling biomarkers in hypertensive patients. Hypertens Res 2011,34(1),145-151","journal-title":"Hypertens Res"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1373\/clinchem.2017.275289","volume":"63","author":"Jagodzinski A.","year":"2017","unstructured":"Jagodzinski A.; Neumann J.T.; Ojeda F.; S\u00f6rensen N.A.; Wild P.; M\u00fcnzel T.; Zeller T.; Westermann D.; Blankenberg S.; Cardiovascular biomarkers in hypertensive patients with medical treatment\u2014results from the randomized TEAMSTA protect I trial. Clin Chem 2017,63(12),1877-1885","journal-title":"Clin Chem"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1042\/CS20160407","volume":"131","author":"Savoia C.","year":"2017","unstructured":"Savoia C.; Volpe M.; Grassi G.; Borghi C.; Agabiti Rosei E.; Touyz R.M.; Personalized medicine\u2014a modern approach for the diagnosis and management of hypertension. Clin Sci (Lond) 2017,131(22),2671-2685","journal-title":"Clin Sci (Lond)"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s40618-016-0529-2","volume":"40","author":"Fang P.","year":"2017","unstructured":"Fang P.; Yu M.; Gu X.; Shi M.; Zhu Y.; Zhang Z.; Bo P.; Low levels of plasma galanin in obese subjects with hypertension. J Endocrinol Invest 2017,40(1),63-68","journal-title":"J Endocrinol Invest"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/5584_2016_79","volume":"956","author":"Au A.","year":"2016","unstructured":"Au A.; Cheng K.K.; Wei L.K.; Metabolomics, lipidomics and pharmacometabolomics of human hypertension. Adv Exp Med Biol 2016,956,599-613","journal-title":"Adv Exp Med Biol"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1161\/CIRCRESAHA.116.303647","volume":"116","author":"Padmanabhan S.","year":"2015","unstructured":"Padmanabhan S.; Caulfield M.; Dominiczak A.F.; Genetic and molecular aspects of hypertension. Circ Res 2015,116(6),937-959","journal-title":"Circ Res"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/ng.3768","volume":"49","author":"Warren H.R.","year":"2017","unstructured":"Warren H.R.; Evangelou E.; Cabrera C.P.; Gao H.; Ren M.; Mifsud B.; Ntalla I.; Surendran P.; Liu C.; Cook J.P.; Kraja A.T.; Drenos F.; Loh M.; Verweij N.; Marten J.; Karaman I.; Lepe M.P.S.; O\u2019Reilly P.F.; Knight J.; Snieder H.; Kato N.; He J.; Tai E.S.; Said M.A.; Porteous D.; Alver M.; Poulter N.; Farrall M.; Gansevoort R.T.; Padmanabhan S.; M\u00e4gi R.; Stanton A.; Connell J.; Bakker S.J.L.; Metspalu A.; Shields D.C.; Thom S.; Brown M.; Sever P.; Esko T.; Hayward C.; van der Harst P.; Saleheen D.; Chowdhury R.; Chambers J.C.; Chasman D.I.; Chakravarti A.; Newton-Cheh C.; Lindgren C.M.; Levy D.; Kooner J.S.; Keavney B.; Tomaszewski M.; Samani N.J.; Howson J.M.M.; Tobin M.D.; Munroe P.B.; Ehret G.B.; Wain L.V.; Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk. Nat Genet 2017,49(3),403-415","journal-title":"Nat Genet"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1096\/fj.01-0735com","volume":"16","author":"Takimoto E.","year":"2002","unstructured":"Takimoto E.; Yao A.; Toko H.; Takano H.; Shimoyama M.; Sonoda M.; Wakimoto K.; Takahashi T.; Akazawa H.; Mizukami M.; Nagai T.; Nagai R.; Komuro I.; Sodium calcium exchanger plays a key role in alteration of cardiac function in response to pressure overload. FASEB J 2002,16(3),373-378","journal-title":"FASEB J"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"18255","DOI":"10.1073\/pnas.0608791103","volume":"103","author":"van Rooij E.","year":"2006","unstructured":"van Rooij E.; Sutherland L.B.; Liu N.; Williams A.H.; McAnally J.; Gerard R.D.; Richardson J.A.; Olson E.N.; A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA 2006,103(48),18255-18260","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.bbrc.2010.03.075","volume":"394","author":"Hoekstra M.","year":"2010","unstructured":"Hoekstra M.; van der Lans C.A.C.; Halvorsen B.; Gullestad L.; Kuiper J.; Aukrust P.; van Berkel T.J.C.; Biessen E.A.L.; The peripheral blood mononuclear cell microRNA signature of coronary artery disease. Biochem Biophys Res Commun 2010,394(3),792-797","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11906-011-0235-6","volume":"14","author":"B\u00e1tkai S.","year":"2012","unstructured":"B\u00e1tkai S.; Thum T.; MicroRNAs in hypertension: Mechanisms and therapeutic targets. Curr Hypertens Rep 2012,14(1),79-87","journal-title":"Curr Hypertens Rep"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1161\/HYPERTENSIONAHA.119.13412","volume":"74","author":"Jusic A.","year":"2019","unstructured":"Jusic A.; Devaux Y.; Action E.U-C.C.; Noncoding RNAs in hypertension. Hypertension 2019,74(3),477-492","journal-title":"Hypertension"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1097\/HJH.0b013e3283614c1c","volume":"31","author":"Morillas P.","year":"2013","unstructured":"Morillas P.; Quiles J.; de Andrade H.; Castillo J.; Taraz\u00f3n E.; Rosell\u00f3 E.; Portol\u00e9s M.; Rivera M.; Bertomeu-Mart\u00ednez V.; Circulating biomarkers of collagen metabolism in arterial hypertension. J Hypertens 2013,31(8),1611-1617","journal-title":"J Hypertens"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1161\/HYPERTENSIONAHA.116.07412","volume":"68","author":"Baldan-Martin M.","year":"2016","unstructured":"Baldan-Martin M.; Mourino-Alvarez L.; Gonzalez-Calero L.; Moreno-Luna R.; Sastre-Oliva T.; Ruiz-Hurtado G.; Segura J.; Lopez J.A.; Vazquez J.; Vivanco F.; Alvarez-Llamas G.; Ruilope L.M.; de la Cuesta F.; Barderas M.G.; Plasma molecular signatures in hypertensive patients with renin\u2013angiotensin system suppression. Hypertension 2016,68(1),157-166","journal-title":"Hypertension"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1093\/eurheartj\/ehs185","volume":"33","author":"Kuznetsova T.","year":"2012","unstructured":"Kuznetsova T.; Mischak H.; Mullen W.; Staessen J.A.; Urinary proteome analysis in hypertensive patients with left ventricular diastolic dysfunction. Eur Heart J 2012,33(18),2342-2350","journal-title":"Eur Heart J"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1161\/HYPERTENSIONAHA.116.08906","volume":"70","author":"Gajjala P.R.","year":"2017","unstructured":"Gajjala P.R.; Jankowski V.; Heinze G.; Bilo G.; Zanchetti A.; Noels H.; Liehn E.; Perco P.; Schulz A.; Delles C.; Kork F.; Biessen E.; Narkiewicz K.; Kawecka-Jaszcz K.; Floege J.; Soranna D.; Zidek W.; Jankowski J.; Proteomic-biostatistic integrated approach for finding the underlying molecular determinants of hypertension in human plasma. Hypertension 2017,70(2),412-419","journal-title":"Hypertension"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s11906-014-0433-0","volume":"16","author":"Etelvino G.M.","year":"2014","unstructured":"Etelvino G.M.; Peluso A.A.B.; Santos R.A.S.; New components of the renin-angiotensin system: Alamandine and the MAS-related G protein-coupled receptor D. Curr Hypertens Rep 2014,16(6),433","journal-title":"Curr Hypertens Rep"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1161\/CIRCRESAHA.113.301077","volume":"112","author":"Lautner R.Q.","year":"2013","unstructured":"Lautner R.Q.; Villela D.C.; Fraga-Silva R.A.; Silva N.; Verano-Braga T.; Costa-Fraga F.; Jankowski J.; Jankowski V.; Sousa F.; Alzamora A.; Soares E.; Barbosa C.; Kjeldsen F.; Oliveira A.; Braga J.; Savergnini S.; Maia G.; Peluso A.B.; Passos-Silva D.; Ferreira A.; Alves F.; Martins A.; Raizada M.; Paula R.; Motta-Santos D.; Kemplin F.; Pimenta A.; Alenina N.; Sinisterra R.; Bader M.; Campagnole-Santos M.J.; Santos R.A.S.; Discovery and characterization of alamandine: A novel component of the renin-angiotensin system. Circ Res 2013,112(8),1104-1111","journal-title":"Circ Res"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1042\/CS20180547","volume":"133","author":"de Souza-Neto F.P.","year":"2019","unstructured":"de Souza-Neto F.P.; Silva M.M.; Santuchi M.C.; de Alc\u00e2ntara-Leon\u00eddio T.C.; Motta-Santos D.; Oliveira A.C.; Melo M.B.; Canta G.N.; de Souza L.E.; Irigoyen M.C.C.; Campagnole-Santos M.J.; Guatimosim S.; Santos R.A.S.; da Silva R.F.; Alamandine attenuates arterial remodelling induced by transverse aortic constriction in mice. Clin Sci (Lond) 2019,133(5),629-643","journal-title":"Clin Sci (Lond)"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"C740","DOI":"10.1152\/ajpcell.00153.2019","volume":"318","author":"Jesus I.C.G.","year":"2020","unstructured":"Jesus I.C.G.; Mesquita T.R.R.; Monteiro A.L.L.; Parreira A.B.; Santos A.K.; Coelho E.L.X.; Silva M.M.; Souza L.A.C.; Campagnole-Santos M.J.; Santos R.S.; Guatimosim S.; Alamandine enhances cardiomyocyte contractility in hypertensive rats through a nitric oxide-dependent activation of CaMKII. Am J Physiol Cell Physiol 2020,318(4),C740-C750","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.peptides.2017.09.005","volume":"96","author":"Soares E.R.","year":"2017","unstructured":"Soares E.R.; Barbosa C.M.; Campagnole-Santos M.J.; Santos R.A.S.; Alzamora A.C.; Hypotensive effect induced by microinjection of Alamandine, a derivative of angiotensin-(1\u20137), into caudal ventrolateral medulla of 2K1C hypertensive rats. Peptides 2017,96,67-75","journal-title":"Peptides"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"C702","DOI":"10.1152\/ajpcell.00153.2017","volume":"314","author":"Jesus I.C.G.","year":"2018","unstructured":"Jesus I.C.G.; Scalzo S.; Alves F.; Marques K.; Rocha-Resende C.; Bader M.; Santos R.A.S.; Guatimosim S.; Alamandine acts via MrgD to induce AMPK\/NO activation against ANG II hypertrophy in cardiomyocytes. Am J Physiol Cell Physiol 2018,314(6),C702-C711","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"H123","DOI":"10.1152\/ajpheart.00075.2018","volume":"316","author":"Oliveira A.C.","year":"2019","unstructured":"Oliveira A.C.; Melo M.B.; Motta-Santos D.; Peluso A.A.; Souza-Neto F.; da Silva R.F.; Almeida J.F.Q.; Canta G.; Reis A.M.; Goncalves G.; Cerri G.; Coutinho D.; Guedes de Jesus I.C.; Guatimosim S.; Linhares N.D.; Alenina N.; Bader M.; Campagnole-Santos M.J.; Santos R.A.S.; Genetic deletion of the alamandine receptor MRGD leads to dilated cardiomyopathy in mice. Am J Physiol Heart Circ Physiol 2019,316(1),H123-H133","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.cca.2018.08.006","volume":"486","author":"Zhao H.","year":"2018","unstructured":"Zhao H.; Liu Y.; Li Z.; Song Y.; Cai X.; Liu Y.; Zhang T.; Yang L.; Li L.; Gao S.; Li Y.; Yu C.; Identification of essential hypertension biomarkers in human urine by non-targeted metabolomics based on UPLC-Q-TOF\/MS. Clin Chim Acta 2018,486,192-198","journal-title":"Clin Chim Acta"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11306-018-1408-y","volume":"14","author":"Ke C.","year":"2018","unstructured":"Ke C.; Zhu X.; Zhang Y.; Shen Y.; Metabolomic characterization of hypertension and dyslipidemia. Meta- bolomics 2018,14(9),117","journal-title":"Meta- bolomics"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/aje\/kwu143","volume":"180","author":"Tzoulaki I.","year":"2014","unstructured":"Tzoulaki I.; Ebbels T.M.D.; Valdes A.; Elliott P.; Ioannidis J.P.A.; Design and analysis of metabolomics studies in epidemiologic research: A primer on -omic technologies. Am J Epidemiol 2014,180(2),129-139","journal-title":"Am J Epidemiol"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/S0140-6736(16)31679-8","volume":"388","author":"Forouzanfar M.H.","year":"2016","unstructured":"Forouzanfar M.H.; Afshin A.; Alexander L.T.; Anderson H.R.; Bhutta Z.A.; Biryukov S.; Brauer M.; Burnett R.; Cercy K.; Charlson F.J.; Cohen A.J.; Dandona L.; Estep K.; Ferrari A.J.; Frostad J.J.; Fullman N.; Gething P.W.; Godwin W.W.; Griswold M.; Hay S.I.; Kinfu Y.; Kyu H.H.; Larson H.J.; Liang X.; Lim S.S.; Liu P.Y.; Lopez A.D.; Lozano R.; Marczak L.; Mensah G.A.; Mokdad A.H.; Moradi-Lakeh M.; Naghavi M.; Neal B.; Reitsma M.B.; Roth G.A.; Salomon J.A.; Sur P.J.; Vos T.; Wagner J.A.; Wang H.; Zhao Y.; Zhou M.; Aasvang G.M.; Abajobir A.A.; Abate K.H.; Abbafati C.; Abbas K.M.; Abd-Allah F.; Abdulle A.M.; Abera S.F.; Abraham B.; Abu-Raddad L.J.; Abyu G.Y.; Adebiyi A.O.; Adedeji I.A.; Ademi Z.; Adou A.K.; Adsuar J.C.; Agardh E.E.; Agarwal A.; Agrawal A.; Kiadaliri A.A.; Ajala O.N.; Akinyemiju T.F.; Al-Aly Z.; Alam K.; Alam N.K.M.; Aldhahri S.F.; Aldridge R.W.; Alemu Z.A.; Ali R.; Alkerwi A.; Alla F.; Allebeck P.; Alsharif U.; Altirkawi K.A.; Martin E.A.; Alvis-Guzman N.; Amare A.T.; Amberbir A.; Amegah A.K.; Amini H.; Ammar W.; Amrock S.M.; Andersen H.H.; Anderson B.O.; Antonio C.A.T.; Anwari P.; \u00c4rnl\u00f6v J.; Artaman A.; Asayesh H.; Asghar R.J.; Assadi R.; Atique S.; Avokpaho E.F.G.A.; Awasthi A.; Quintanilla B.P.A.; Azzopardi P.; Bacha U.; Badawi A.; Bahit M.C.; Balakrishnan K.; Barac A.; Barber R.M.; Barker-Collo S.L.; B\u00e4rnighausen T.; Barquera S.; Barregard L.; Barrero L.H.; Basu S.; Batis C.; Bazargan-Hejazi S.; Beardsley J.; Bedi N.; Beghi E.; Bell B.; Bell M.L.; Bello A.K.; Bennett D.A.; Bensenor I.M.; Berhane A.; Bernab\u00e9 E.; Betsu B.D.; Beyene A.S.; Bhala N.; Bhansali A.; Bhatt S.; Biadgilign S.; Bikbov B.; Bisanzio D.; Bjertness E.; Blore J.D.; Borschmann R.; Boufous S.; Bourne R.R.A.; Brainin M.; Brazinova A.; Breitborde N.J.K.; Brenner H.; Broday D.M.; Brugha T.S.; Brunekreef B.; Butt Z.A.; Cahill L.E.; Calabria B.; Campos-Nonato I.R.; C\u00e1rdenas R.; Carpenter D.O.; Carrero J.J.; Casey D.C.; Casta\u00f1eda-Orjuela C.A.; Rivas J.C.; Castro R.E.; Catal\u00e1-L\u00f3pez F.; Chang J-C.; Chiang P.P-C.; Chibalabala M.; Chimed-Ochir O.; Chisumpa V.H.; Chitheer A.A.; Choi J-Y.J.; Christensen H.; Christopher D.J.; Ciobanu L.G.; Coates M.M.; Colquhoun S.M.; Manzano A.G.C.; Cooper L.T.; Cooperrider K.; Cornaby L.; Cortinovis M.; Crump J.A.; Cuevas-Nasu L.; Damasceno A.; Dandona R.; Darby S.C.; Dargan P.I.; das Neves J.; Davis A.C.; Davletov K.; de Castro E.F.; De la Cruz-G\u00f3ngora V.; De Leo D.; Degenhardt L.; Del Gobbo L.C.; del Pozo-Cruz B.; Dellavalle R.P.; Deribew A.; Jarlais D.C.D.; Dharmaratne S.D.; Dhillon P.K.; Diaz-Torn\u00e9 C.; Dicker D.; Ding E.L.; Dorsey E.R.; Doyle K.E.; Driscoll T.R.; Duan L.; Dubey M.; Duncan B.B.; Elyazar I.; Endries A.Y.; Ermakov S.P.; Erskine H.E.; Eshrati B.; Esteghamati A.; Fahimi S.; Faraon E.J.A.; Farid T.A.; Farinha C.S.S.; Faro A.; Farvid M.S.; Farzadfar F.; Feigin V.L.; Fereshtehnejad S-M.; Fernandes J.G.; Fischer F.; Fitchett J.R.A.; Fleming T.; Foigt N.; Foreman K.; Fowkes F.G.R.; Franklin R.C.; F\u00fcrst T.; Futran N.D.; Gakidou E.; Garcia-Basteiro A.L.; Gebrehiwot T.T.; Gebremedhin A.T.; Geleijnse J.M.; Gessner B.D.; Giref A.Z.; Giroud M.; Gishu M.D.; Giussani G.; Goenka S.; Gomez-Cabrera M.C.; Gomez-Dantes H.; Gona P.; Goodridge A.; Gopalani S.V.; Gotay C.C.; Goto A.; Gouda H.N.; Gugnani H.C.; Guillemin F.; Guo Y.; Gupta R.; Gupta R.; Guti\u00e9rrez R.A.; Haagsma J.A.; Hafezi-Nejad N.; Haile D.; Hailu G.B.; Halasa Y.A.; Hamadeh R.R.; Hamidi S.; Handal A.J.; Hankey G.J.; Hao Y.; Harb H.L.; Harikrishnan S.; Haro J.M.; Hassanvand M.S.; Hassen T.A.; Havmoeller R.; Heredia-Pi I.B.; Hern\u00e1ndez-Llanes N.F.; Heydarpour P.; Hoek H.W.; Hoffman H.J.; Horino M.; Horita N.; Hosgood H.D.; Hoy D.G.; Hsairi M.; Htet A.S.; Hu G.; Huang J.J.; Husseini A.; Hutchings S.J.; Huybrechts I.; Iburg K.M.; Idrisov B.T.; Ileanu B.V.; Inoue M.; Jacobs T.A.; Jacobsen K.H.; Jahanmehr N.; Jakovljevic M.B.; Jansen H.A.F.M.; Jassal S.K.; Javanbakht M.; Jayaraman S.P.; Jayatilleke A.U.; Jee S.H.; Jeemon P.; Jha V.; Jiang Y.; Jibat T.; Jin Y.; Johnson C.O.; Jonas J.B.; Kabir Z.; Kalkonde Y.; Kamal R.; Kan H.; Karch A.; Karema C.K.; Karimkhani C.; Kasaeian A.; Kaul A.; Kawakami N.; Kazi D.S.; Keiyoro P.N.; Kemmer L.; Kemp A.H.; Kengne A.P.; Keren A.; Kesavachandran C.N.; Khader Y.S.; Khan A.R.; Khan E.A.; Khan G.; Khang Y-H.; Khatibzadeh S.; Khera S.; Khoja T.A.M.; Khubchandani J.; Kieling C.; Kim C.; Kim D.; Kimokoti R.W.; Kissoon N.; Kivipelto M.; Knibbs L.D.; Kokubo Y.; Kopec J.A.; Koul P.A.; Koyanagi A.; Kravchenko M.; Kromhout H.; Krueger H.; Ku T.; Defo B.K.; Kuchenbecker R.S.; Bicer B.K.; Kuipers E.J.; Kumar G.A.; Kwan G.F.; Lal D.K.; Lalloo R.; Lallukka T.; Lan Q.; Larsson A.; Latif A.A.; Lawrynowicz A.E.B.; Leasher J.L.; Leigh J.; Leung J.; Levi M.; Li X.; Li Y.; Liang J.; Liu S.; Lloyd B.K.; Logroscino G.; Lotufo P.A.; Lunevicius R.; MacIntyre M.; Mahdavi M.; Majdan M.; Majeed A.; Malekzadeh R.; Malta D.C.; Manamo W.A.A.; Mapoma C.C.; Marcenes W.; Martin R.V.; Martinez-Raga J.; Masiye F.; Matsushita K.; Matzopoulos R.; Mayosi B.M.; McGrath J.J.; McKee M.; Meaney P.A.; Medina C.; Mehari A.; Mejia-Rodriguez F.; Mekonnen A.B.; Melaku Y.A.; Memish Z.A.; Mendoza W.; Mensink G.B.M.; Meretoja A.; Meretoja T.J.; Mesfin Y.M.; Mhimbira F.A.; Millear A.; Miller T.R.; Mills E.J.; Mirarefin M.; Misganaw A.; Mock C.N.; Mohammadi A.; Mohammed S.; Mola G.L.D.; Monasta L.; Hernandez J.C.M.; Montico M.; Morawska L.; Mori R.; Mozaffarian D.; Mueller U.O.; Mullany E.; Mumford J.E.; Murthy G.V.S.; Nachega J.B.; Naheed A.; Nangia V.; Nassiri N.; Newton J.N.; Ng M.; Nguyen Q.L.; Nisar M.I.; Pete P.M.N.; Norheim O.F.; Norman R.E.; Norrving B.; Nyakarahuka L.; Obermeyer C.M.; Ogbo F.A.; Oh I-H.; Oladimeji O.; Olivares P.R.; Olsen H.; Olusanya B.O.; Olusanya J.O.; Opio J.N.; Oren E.; Orozco R.; Ortiz A.; Ota E.; Pa M.; Pana A.; Park E-K.; Parry C.D.; Parsaeian M.; Patel T.; Caicedo A.J.P.; Patil S.T.; Patten S.B.; Patton G.C.; Pearce N.; Pereira D.M.; Perico N.; Pesudovs K.; Petzold M.; Phillips M.R.; Piel F.B.; Pillay J.D.; Plass D.; Polinder S.; Pond C.D.; Pope C.A.; Pope D.; Popova S.; Poulton R.G.; Pourmalek F.; Prasad N.M.; Qorbani M.; Rabiee R.H.S.; Radfar A.; Rafay A.; Rahimi-Movaghar V.; Rahman M.; Rahman M.H.U.; Rahman S.U.; Rai R.K.; Rajsic S.; Raju M.; Ram U.; Rana S.M.; Ranganathan K.; Rao P.; Garc\u00eda C.A.R.; Refaat A.H.; Rehm C.D.; Rehm J.; Reinig N.; Remuzzi G.; Resnikoff S.; Ribeiro A.L.; Rivera J.A.; Roba H.S.; Rodriguez A.; Rodriguez-Ramirez S.; Rojas-Rueda D.; Roman Y.; Ronfani L.; Roshandel G.; Rothenbacher D.; Roy A.; Saleh M.M.; Sanabria J.R.; Sanchez-Riera L.; Sanchez-Ni\u00f1o M.D.; S\u00e1nchez-Pimienta T.G.; Sandar L.; Santomauro D.F.; Santos I.S.; Sarmiento-Suarez R.; Sartorius B.; Satpathy M.; Savic M.; Sawhney M.; Schmidhuber J.; Schmidt M.I.; Schneider I.J.C.; Sch\u00f6ttker B.; Schutte A.E.; Schwebel D.C.; Scott J.G.; Seedat S.; Sepanlou S.G.; Servan-Mori E.E.; Shaddick G.; Shaheen A.; Shahraz S.; Shaikh M.A.; Levy T.S.; Sharma R.; She J.; Sheikhbahaei S.; Shen J.; Sheth K.N.; Shi P.; Shibuya K.; Shigematsu M.; Shin M-J.; Shiri R.; Shishani K.; Shiue I.; Shrime M.G.; Sigfusdottir I.D.; Silva D.A.S.; Silveira D.G.A.; Silverberg J.I.; Simard E.P.; Sindi S.; Singh A.; Singh J.A.; Singh P.K.; Slepak E.L.; Soljak M.; Soneji S.; Sorensen R.J.D.; Sposato L.A.; Sreeramareddy C.T.; Stathopoulou V.; Steckling N.; Steel N.; Stein D.J.; Stein M.B.; St\u00f6ckl H.; Stranges S.; Stroumpoulis K.; Sunguya B.F.; Swaminathan S.; Sykes B.L.; Szoeke C.E.I.; Tabar\u00e9s-Seisdedos R.; Takahashi K.; Talongwa R.T.; Tandon N.; Tanne D.; Tavakkoli M.; Taye B.W.; Taylor H.R.; Tedla B.A.; Tefera W.M.; Tegegne T.K.; Tekle D.Y.; Terkawi A.S.; Thakur J.S.; Thomas B.A.; Thomas M.L.; Thomson A.J.; Thorne-Lyman A.L.; Thrift A.G.; Thurston G.D.; Tillmann T.; Tobe-Gai R.; Tobollik M.; Topor-Madry R.; Topouzis F.; Towbin J.A.; Tran B.X.; Dimbuene Z.T.; Tsilimparis N.; Tura A.K.; Tuzcu E.M.; Tyrovolas S.; Ukwaja K.N.; Undurraga E.A.; Uneke C.J.; Uthman O.A.; van Donkelaar A.; van Os J.; Varakin Y.Y.; Vasankari T.; Veerman J.L.; Venketasubramanian N.; Violante F.S.; Vollset S.E.; Wagner G.R.; Waller S.G.; Wang J.L.; Wang L.; Wang Y.; Weichenthal S.; Weiderpass E.; Weintraub R.G.; Werdecker A.; Westerman R.; Whiteford H.A.; Wijeratne T.; Wiysonge C.S.; Wolfe C.D.A.; Won S.; Woolf A.D.; Wubshet M.; Xavier D.; Xu G.; Yadav A.K.; Yakob B.; Yalew A.Z.; Yano Y.; Yaseri M.; Ye P.; Yip P.; Yonemoto N.; Yoon S-J.; Younis M.Z.; Yu C.; Zaidi Z.; Zaki M.E.S.; Zhu J.; Zipkin B.; Zodpey S.; Zuhlke L.J.; Murray C.J.L.; Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990\u20132015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016,388(10053),1659-1724","journal-title":"Lancet"},{"key":"ref=143","first-page":"P1105","volume":"75","author":"Oparil S.","year":"2000","unstructured":"Oparil S.; Weber M.A.; Hypertension: A companion to Brenner and Rector\u2019s. Mayo Clin Proc 2000,75(10),P1105","journal-title":"Mayo Clin Proc"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","volume":"135","author":"Benjamin E.J.","year":"2017","unstructured":"Benjamin E.J.; Blaha M.J.; Chiuve S.E.; Cushman M.; Das S.R.; Deo R.; de Ferranti S.D.; Floyd J.; Fornage M.; Gillespie C.; Isasi C.R.; Jim\u00e9nez M.C.; Jordan L.C.; Judd S.E.; Lackland D.; Lichtman J.H.; Lisabeth L.; Liu S.; Longenecker C.T.; Mackey R.H.; Matsushita K.; Mozaffarian D.; Mussolino M.E.; Nasir K.; Neumar R.W.; Palaniappan L.; Pandey D.K.; Thiagarajan R.R.; Reeves M.J.; Ritchey M.; Rodriguez C.J.; Roth G.A.; Rosamond W.D.; Sasson C.; Towfighi A.; Tsao C.W.; Turner M.B.; Virani S.S.; Voeks J.H.; Willey J.Z.; Wilkins J.T.; Wu J.H.Y.; Alger H.M.; Wong S.S.; Muntner P.; Heart disease and stroke statistics\u20142017 update: A report from the American heart association. Circulation 2017,135(10),e146-e603","journal-title":"Circulation"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/bs.acc.2018.02.002","volume":"85","author":"Au A.","year":"2018","unstructured":"Au A.; Metabolomics and lipidomics of ischemic stroke. Adv Clin Chem 2018,85,31-69","journal-title":"Adv Clin Chem"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"5483","DOI":"10.1007\/s12035-018-1440-y","volume":"56","author":"Thakkar M.","year":"2019","unstructured":"Thakkar M.; Edelenbos J.; Dor\u00e9 S.; Bilirubin and ischemic stroke: Rendering the current paradigm to better understand the protective effects of bilirubin. Mol Neurobiol 2019,56(8),5483-5496","journal-title":"Mol Neurobiol"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11936-019-0778-4","volume":"21","author":"Sloane K.L.","year":"2019","unstructured":"Sloane K.L.; Camargo E.C.; Antithrombotic management of ischemic stroke. Curr Treat Options Cardiovasc Med 2019,21(11),78","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.str.24.1.35","volume":"24","author":"Adams HP","year":"1993","unstructured":"Adams HP; Bendixen BH; Kappelle LJ; Biller J; Love BB; Gordon DL.; Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993,24(1),35-41","journal-title":"Stroke"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.3390\/ijms17121967","volume":"17","author":"Bonaventura A.","year":"2016","unstructured":"Bonaventura A.; Liberale L.; Vecchi\u00e9 A.; Casula M.; Carbone F.; Dallegri F.; Montecucco F.; Update on inflammatory biomarkers and treatments in ischemic stroke. Int J Mol Sci 2016,17(12),1967","journal-title":"Int J Mol Sci"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.12.035","volume":"28","author":"Guo X.","year":"2019","unstructured":"Guo X.; Li Z.; Zhou Y.; Yu S.; Yang H.; Zheng L.; Liu Y.; Sun Y.; Metabolic profile for prediction of ischemic stroke in Chinese hypertensive population. J Stroke Cerebrovasc Dis 2019,28(4),1062-1069","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3389\/fphys.2016.00106","volume":"7","author":"Melo D.S.","year":"2016","unstructured":"Melo D.S.; Costa-Pereira L.V.; Santos C.S.; Mendes B.F.; Costa K.B.; Santos C.F.F.; Rocha-Vieira E.; Magalh\u00e3es F.C.; Esteves E.A.; Ferreira A.J.; Guatimosim S.; Dias-Peixoto M.F.; Severe calorie restriction reduces cardiometabolic risk factors and protects rat hearts from ischemia\/reperfusion injury. Front Physiol 2016,7,106","journal-title":"Front Physiol"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1080\/15548627.2017.1325062","volume":"13","author":"Campos J.C.","year":"2017","unstructured":"Campos J.C.; Queliconi B.B.; Bozi L.H.M.; Bechara L.R.G.; Dourado P.M.M.; Andres A.M.; Jannig P.R.; Gomes K.M.S.; Zambelli V.O.; Rocha-Resende C.; Guatimosim S.; Brum P.C.; Mochly-Rosen D.; Gottlieb R.A.; Kowaltowski A.J.; Ferreira J.C.B.; Exercise reestablishes autophagic flux and mitochondrial quality control in heart failure. Autophagy 2017,13(8),1304-1317","journal-title":"Autophagy"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1159\/000199468","volume":"27","author":"Dassan P.","year":"2009","unstructured":"Dassan P.; Keir G.; Brown M.M.; Criteria for a clinically informative serum biomarker in acute ischaemic stroke: A review of S100B. Cerebrovasc Dis 2009,27(3),295-302","journal-title":"Cerebrovasc Dis"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1080\/10408363.2018.1461190","volume":"55","author":"Makris K.","year":"2018","unstructured":"Makris K.; Haliassos A.; Chondrogianni M.; Tsivgoulis G.; Blood biomarkers in ischemic stroke: Potential role and challenges in clinical practice and research. Crit Rev Clin Lab Sci 2018,55(5),294-328","journal-title":"Crit Rev Clin Lab Sci"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1161\/01.CIR.0000152105.79665.C6","volume":"111","author":"Moore D.F.","year":"2005","unstructured":"Moore D.F.; Li H.; Jeffries N.; Wright V.; Cooper R.A.; Elkahloun A.; Gelderman M.P.; Zudaire E.; Blevins G.; Yu H.; Goldin E.; Baird A.E.; Using peripheral blood mononuclear cells to determine a gene expression profile of acute ischemic stroke: A pilot investigation. Circulation 2005,111(2),212-221","journal-title":"Circulation"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1161\/CIRCRESAHA.116.310283","volume":"120","author":"Guo Y.","year":"2017","unstructured":"Guo Y.; VanDusen N.J.; Zhang L.; Gu W.; Sethi I.; Guatimosim S.; Ma Q.; Jardin B.D.; Ai Y.; Zhang D.; Chen B.; Guo A.; Yuan G.C.; Song L.S.; Pu W.T.; Analysis of cardiac myocyte maturation using CASAAV, a platform for rapid dissection of cardiac myocyte gene function in vivo. Circ Res 2017,120(12),1874-1888","journal-title":"Circ Res"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/acel.12252","volume":"13","author":"Che P.","year":"2014","unstructured":"Che P.; Liu J.; Shan Z.; Wu R.; Yao C.; Cui J.; Zhu X.; Wang J.; Burnett M.S.; Wang S.; Wang J.; miR-125a-5p impairs endothelial cell angiogenesis in aging mice via  -1 downregulation. Aging Cell 2014,13(5),926-934","journal-title":"Aging Cell"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/onc.2012.68","volume":"32","author":"Muramatsu F.","year":"2013","unstructured":"Muramatsu F.; Kidoya H.; Naito H.; Sakimoto S.; Takakura N.; microRNA-125b inhibits tube formation of blood vessels through translational suppression of VE-cadherin. Oncogene 2013,32(4),414-421","journal-title":"Oncogene"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1161\/CIRCRESAHA.117.311572","volume":"121","author":"Tiedt S.","year":"2017","unstructured":"Tiedt S.; Prestel M.; Malik R.; Schieferdecker N.; Duering M.; Kautzky V.; Stoycheva I.; B\u00f6ck J.; Northoff B.H.; Klein M.; Dorn F.; Krohn K.; Teupser D.; Liesz A.; Plesnila N.; Holdt L.M.; Dichgans M.; RNA-Seq identifies circulating miR-125a-5p, miR-125b-5p, and miR-143-3p as potential biomarkers for acute ischemic stroke. Circ Res 2017,121(8),970-980","journal-title":"Circ Res"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1160\/TH16-08-0606","volume":"117","author":"Wang C.","year":"2017","unstructured":"Wang C.; Song J.; Lv Q.; Pan H.; Zhang C.; Wu J.; Fan C.; Ma L.; Liu T.; Wang J.; Distinctive expression signatures of serum microRNAs in ischaemic stroke and transient ischaemic attack patients. Thromb Haemost 2017,117(5),992-1001","journal-title":"Thromb Haemost"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s11011-017-9953-z","volume":"32","author":"Xue L.","year":"2017","unstructured":"Xue L.; Chen H.; Zhang T.; Chen J.; Geng Z.; Zhao Y.; Changes in serum vascular endothelial growth factor and endostatin concentrations associated with circulating endothelial progenitor cells after acute ischemic stroke. Metab Brain Dis 2017,32(2),641-648","journal-title":"Metab Brain Dis"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s12975-019-00747-2","volume":"11","author":"Sobrino T.","year":"2020","unstructured":"Sobrino T.; Rodr\u00edguez-Y\u00e1\u00f1ez M.; Campos F.; Iglesias-Rey R.; Mill\u00e1n M.; de la Ossa N.P.; D\u00e1valos A.; Delgado-Mederos R.; Mart\u00ednez-Dome\u00f1o A.; Mart\u00ed-F\u00e1bregas J.; Castellanos M.; Serena J.; Lago A.; D\u00edez-Tejedor E.; Castillo J.; Association of high serum levels of growth factors with good outcome in ischemic stroke: A multicenter study. Transl Stroke Res 2020,11(4),653-663","journal-title":"Transl Stroke Res"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.neuroscience.2014.04.054","volume":"271","author":"Pinto M.C.X.","year":"2014","unstructured":"Pinto M.C.X.; Sim\u00e3o F.; da Costa F.L.P.; Rosa D.V.; de Paiva M.J.N.; Resende R.R.; Romano-Silva M.A.; Gomez M.V.; Gomez R.S.; Sarcosine preconditioning induces ischemic tolerance against global cerebral ischemia. Neuroscience 2014,271,160-169","journal-title":"Neuroscience"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3389\/fneur.2020.00448","volume":"11","author":"Nielsen H.H.","year":"2020","unstructured":"Nielsen H.H.; Soares C.B.; H\u00f8gedal S.S.; Madsen J.S.; Hansen R.B.; Christensen A.A.; Madsen C.; Clausen B.H.; Frich L.H.; Degn M.; Sibbersen C.; Lambertsen K.L.; Acute neurofilament light chain plasma levels correlate with stroke severity and clinical outcome in ischemic stroke patients. Front Neurol 2020,11,448","journal-title":"Front Neurol"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s12974-020-01920-3","volume":"17","author":"Zhao H.","year":"2020","unstructured":"Zhao H.; Li F.; Huang Y.; Zhang S.; Li L.; Yang Z.; Wang R.; Tao Z.; Han Z.; Fan J.; Zheng Y.; Ma Q.; Luo Y.; Prognostic significance of plasma IL-2 and sIL-2R\u03b1 in patients with first-ever ischaemic stroke. J Neuroinflammation 2020,17(1),237","journal-title":"J Neuroinflammation"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.jocn.2013.06.015","volume":"21","author":"VanGilder R.L.","year":"2014","unstructured":"VanGilder R.L.; Davidov D.M.; Stinehart K.R.; Huber J.D.; Turner R.C.; Wilson K.S.; Haney E.; Davis S.M.; Chantler P.D.; Theeke L.; Rosen C.L.; Crocco T.J.; Gutmann L.; Barr T.L.; C-reactive protein and long-term ischemic stroke prognosis. J Clin Neurosci 2014,21(4),547-553","journal-title":"J Clin Neurosci"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"e0156790","DOI":"10.1371\/journal.pone.0156790","volume":"11","author":"Matsuo R.","year":"2016","unstructured":"Matsuo R.; Ago T.; Hata J.; Wakisaka Y.; Kuroda J.; Kuwashiro T.; Kitazono T.; Kamouchi M.; Plasma C-reactive protein and clinical outcomes after acute ischemic stroke: A prospective observational study. PLoS One 2016,11(6),e0156790","journal-title":"PLoS One"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1159\/000356789","volume":"37","author":"Wiseman S.","year":"2014","unstructured":"Wiseman S.; Marlborough F.; Doubal F.; Webb D.J.; Wardlaw J.; Blood markers of coagulation, fibrinolysis, endothelial dysfunction and inflammation in lacunar stroke versus non-lacunar stroke and non-stroke: Systematic review and meta-analysis. Cerebrovasc Dis 2014,37(1),64-75","journal-title":"Cerebrovasc Dis"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jns.2014.11.010","volume":"348","author":"Ye H.","year":"2015","unstructured":"Ye H.; Wang L.; Yang X.K.; Fan L.P.; Wang Y.G.; Guo L.; Serum S100B levels may be associated with cerebral infarction: A meta-analysis. J Neurol Sci 2015,348(1-2),81-88","journal-title":"J Neurol Sci"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"8480468","DOI":"10.1155\/2019\/8480468","volume":"2019","author":"Goulart V.A.","year":"2019","unstructured":"Goulart V.A.; Sena M.M.; Mendes T.O.; Menezes H.C.; Cardeal Z.L.; Paiva M.J.; Amino acid biosignature in plasma among ischemic stroke subtypes. BioMed Res Int 2019,2019,8480468","journal-title":"BioMed Res Int"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1212\/CON.0000000000000672","volume":"24","author":"Ziai W.C.","year":"2018","unstructured":"Ziai W.C.; Carhuapoma J.R.; Intracerebral hemorrhage. Continuum (Minneap Minn) 2018,24(6),1603-1622","journal-title":"Continuum (Minneap Minn)"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s11883-012-0252-1","volume":"14","author":"Ikram M.A.","year":"2012","unstructured":"Ikram M.A.; Wieberdink R.G.; Koudstaal P.J.; International epidemiology of intracerebral hemorrhage. Curr Atheroscler Rep 2012,14(4),300-306","journal-title":"Curr Atheroscler Rep"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S0140-6736(10)60834-3","volume":"376","author":"O\u2019Donnell M.J.","year":"2010","unstructured":"O\u2019Donnell M.J.; Xavier D.; Liu L.; Zhang H.; Chin S.L.; Rao-Melacini P.; Rangarajan S.; Islam S.; Pais P.; McQueen M.J.; Mondo C.; Damasceno A.; Lopez-Jaramillo P.; Hankey G.J.; Dans A.L.; Yusoff K.; Truelsen T.; Diener H.C.; Sacco R.L.; Ryglewicz D.; Czlonkowska A.; Weimar C.; Wang X.; Yusuf S.; Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): A case-control study. Lancet 2010,376(9735),112-123","journal-title":"Lancet"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1161\/HYPERTENSIONAHA.117.09479","volume":"70","author":"Li W.","year":"2017","unstructured":"Li W.; Jin C.; Vaidya A.; Wu Y.; Rexrode K.; Zheng X.; Gurol M.E.; Ma C.; Wu S.; Gao X.; Blood pressure trajectories and the risk of intracerebral hemorrhage and cerebral infarction. Hypertension 2017,70(3),508-514","journal-title":"Hypertension"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1553-2712.2011.01285.x","volume":"19","author":"Fan J.S.","year":"2012","unstructured":"Fan J.S.; Huang H.H.; Chen Y.C.; Yen D.H.T.; Kao W.F.; Huang M.S.; Huang C.I.; Lee C.H.; Emergency department neurologic deterioration in patients with spontaneous intracerebral hemorrhage: Incidence, predictors, and prognostic significance. Acad Emerg Med 2012,19(2),133-138","journal-title":"Acad Emerg Med"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"e472","DOI":"10.1016\/j.wneu.2019.05.186","volume":"129","author":"Zeng Y.","year":"2019","unstructured":"Zeng Y.; Chen R.; Ma M.; Liu B.; Xia J.; Xu H.; Liu Y.; Du X.; Hu Z.; Yang Q.; Zhang L.; Associations of EDNRA and EDNRB Polymorphisms with Intracerebral Hemorrhage. World Neurosurg 2019,129,e472-e477","journal-title":"World Neurosurg"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1001\/jama.2019.14745","volume":"322","author":"Chen T.K.","year":"2019","unstructured":"Chen T.K.; Knicely D.H.; Grams M.E.; Chronic kidney disease diagnosis and management. JAMA 2019,322(13),1294-1304","journal-title":"JAMA"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1373\/clinchem.2016.263335","volume":"63","author":"Luger S.","year":"2017","unstructured":"Luger S.; Witsch J.; Dietz A.; Hamann G.F.; Minnerup J.; Schneider H.; Sitzer M.; Wartenberg K.E.; Niessner M.; Foerch C.; Glial fibrillary acidic protein serum levels distinguish between intracerebral hemorrhage and cerebral ischemia in the early phase of stroke. Clin Chem 2017,63(1),377-385","journal-title":"Clin Chem"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"4758","DOI":"10.1016\/j.jprot.2012.01.033","volume":"75","author":"Montaner J.","year":"2012","unstructured":"Montaner J.; Mendioroz M.; Delgado P.; Garc\u00eda-Berrocoso T.; Giralt D.; Merino C.; Rib\u00f3 M.; Rosell A.; Penalba A.; Fern\u00e1ndez-Cadenas I.; Romero F.; Molina C.; Alvarez-Sab\u00edn J.; Hern\u00e1ndez-Guillamon M.; Differentiating ischemic from hemorrhagic stroke using plasma biomarkers: The S100B\/RAGE pathway. J Proteomics 2012,75(15),4758-4765","journal-title":"J Proteomics"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.3171\/2014.12.JNS142276","volume":"123","author":"Thaler H.W.","year":"2015","unstructured":"Thaler H.W.; Schmidsfeld J.; Pusch M.; Pienaar S.; Wunderer J.; Pittermann P.; Valenta R.; Gleiss A.; Fialka C.; Mousavi M.; Evaluation of S100B in the diagnosis of suspected intracranial hemorrhage after minor head injury in patients who are receiving platelet aggregation inhibitors and in patients 65 years of age and older. J Neurosurg 2015,123(5),1202-1208","journal-title":"J Neurosurg"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.2174\/1389450118666170427151657","volume":"18","author":"Dang B.","year":"2017","unstructured":"Dang B.; Duan X.; Wang Z.; He W.; Chen G.; A therapeutic target of cerebral hemorrhagic stroke: Matrix metalloproteinase-9. Curr Drug Targets 2017,18(12),1358-1366","journal-title":"Curr Drug Targets"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1161\/STROKEAHA.117.017076","volume":"48","author":"Bustamante A.","year":"2017","unstructured":"Bustamante A.; L\u00f3pez-Cancio E.; Pich S.; Penalba A.; Giralt D.; Garc\u00eda-Berrocoso T.; Ferrer-Costa C.; Gasull T.; Hern\u00e1ndez-P\u00e9rez M.; Millan M.; Rubiera M.; Cardona P.; Cano L.; Quesada H.; Terce\u00f1o M.; Silva Y.; Castellanos M.; Garces M.; Revert\u00e9 S.; Ustrell X.; Mar\u00e9s R.; Baiges J.J.; Serena J.; Rubio F.; Salas E.; D\u00e1valos A.; Montaner J.; Blood biomarkers for the early diagnosis of stroke. Stroke 2017,48(9),2419-2425","journal-title":"Stroke"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jns.2019.02.014","volume":"399","author":"Gregorio T.","year":"2019","unstructured":"Gregorio T.; Albuquerque I.; Neves V.; Reinas R.; Pipa S.; Azevedo L.; Chaves P.C.; NT-pro-BNP correlates with disease severity and predicts outcome in cerebral haemorrhage patients: Cohort study. J Neurol Sci 2019,399,51-56","journal-title":"J Neurol Sci"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"101610","DOI":"10.1016\/j.pneurobio.2019.03.003","volume":"178","author":"Zhu H.","year":"2019","unstructured":"Zhu H.; Wang Z.; Yu J.; Yang X.; He F.; Liu Z.; Che F.; Chen X.; Ren H.; Hong M.; Wang J.; Role and mechanisms of cytokines in the secondary brain injury after intracerebral hemorrhage. Prog Neurobiol 2019,178,101610","journal-title":"Prog Neurobiol"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.bbagen.2010.03.011","volume":"1800","author":"Wang W.","year":"2010","unstructured":"Wang W.; Knovich M.A.; Coffman L.G.; Torti F.M.; Torti S.V.; Serum ferritin: Past, present and future. Biochim Biophys Acta, Gen Subj 2010,1800(8),760-769","journal-title":"Biochim Biophys Acta, Gen Subj"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1038\/jcbfm.2009.182","volume":"29","author":"Sobrino T.","year":"2009","unstructured":"Sobrino T.; Arias S.; Rodr\u00edguez-Gonz\u00e1lez R.; Brea D.; Silva Y.; de la Ossa N.P.; Agulla J.; Blanco M.; Pumar J.M.; Serena J.; D\u00e1valos A.; Castillo J.; High serum levels of growth factors are associated with good outcome in intracerebral hemorrhage. J Cereb Blood Flow Metab 2009,29(12),1968-1974","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"21970","DOI":"10.1038\/srep21970","volume":"6","author":"Yang G.","year":"2016","unstructured":"Yang G.; Hu R.; Zhang C.; Qian C.; Luo Q.Q.; Yung W.H.; Ke Y.; Feng H.; Qian Z.M.; A combination of serum iron, ferritin and transferrin predicts outcome in patients with intracerebral hemorrhage. Sci Rep 2016,6(1),21970","journal-title":"Sci Rep"},{"key":"ref=188","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.thromres.2004.08.026","volume":"115","author":"Saloheimo P.","year":"2005","unstructured":"Saloheimo P.; Juvela S.; Riutta A.; Pyhtinen J.; Hillbom M.; Thromboxane and prostacyclin biosynthesis in patients with acute spontaneous intracerebral hemorrhage. Thromb Res 2005,115(5),367-373","journal-title":"Thromb Res"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1161\/01.STR.30.3.546","volume":"30","author":"van Kooten F.","year":"1999","unstructured":"van Kooten F.; Ciabattoni G.; Koudstaal P.J.; Dippel D.W.J.; Patrono C.; Increased platelet activation in the chronic phase after cerebral ischemia and intracerebral hemorrhage. Stroke 1999,30(3),546-549","journal-title":"Stroke"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"020987","DOI":"10.1056\/NEJMsb020987","volume":"2002","author":"Albers G.W.","year":"2002","unstructured":"Albers G.W.; Caplan L.R.; Easton J.D.; Fayad P.B.; Mohr J.; Saver J.L.; Transient ischemic attack\u2014proposal for a new definition. Mass Med Soc 2002,2002,020987","journal-title":"Mass Med Soc"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1159\/000166839","volume":"26","author":"Prabhakaran S.","year":"2008","unstructured":"Prabhakaran S.; Silver A.J.; Warrior L.; McClenathan B.; Lee V.H.; Misdiagnosis of transient ischemic attacks in the emergency room. Cerebrovasc Dis 2008,26(6),630-635","journal-title":"Cerebrovasc Dis"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1001\/jama.284.22.2901","volume":"284","author":"Johnston S.C.","year":"2000","unstructured":"Johnston S.C.; Gress D.R.; Browner W.S.; Sidney S.; Short-term prognosis after emergency department diagnosis of TIA. JAMA 2000,284(22),2901-2906","journal-title":"JAMA"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/S1474-4422(07)70274-0","volume":"6","author":"Giles M.F.","year":"2007","unstructured":"Giles M.F.; Rothwell P.M.; Risk of stroke early after transient ischaemic attack: A systematic review and meta-analysis. Lancet Neurol 2007,6(12),1063-1072","journal-title":"Lancet Neurol"},{"key":"ref=194","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1001\/archinte.167.22.2417","volume":"167","author":"Wu C.M.","year":"2007","unstructured":"Wu C.M.; McLaughlin K.; Lorenzetti D.L.; Hill M.D.; Manns B.J.; Ghali W.A.; Early risk of stroke after transient ischemic attack: A systematic review and meta-analysis. Arch Intern Med 2007,167(22),2417-2422","journal-title":"Arch Intern Med"},{"key":"ref=195","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1212\/WNL.0b013e3181a826ad","volume":"72","author":"Chandratheva A.","year":"2009","unstructured":"Chandratheva A.; Mehta Z.; Geraghty O.C.; Marquardt L.; Rothwell P.M.; Oxford Vascular S.; Population-based study of risk and predictors of stroke in the first few hours after a TIA. Neurology 2009,72(22),1941-1947","journal-title":"Neurology"},{"key":"ref=196","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1212\/CON.0000000000000424","volume":"23","author":"Coutts SB.","year":"2017","unstructured":"Coutts SB.; Diagnosis and management of transient ischemic attack. Continuum (Minneap Minn) 2017,23,82-92","journal-title":"Continuum (Minneap Minn)"},{"key":"ref=197","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s12264-016-0038-5","volume":"32","author":"Li J.","year":"2016","unstructured":"Li J.; Wang Y.; Blood biomarkers in minor stroke and transient ischemic attack. Neurosci Bull 2016,32(5),463-468","journal-title":"Neurosci Bull"},{"key":"ref=198","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1373\/clinchem.2005.053942","volume":"51","author":"Allard L.","year":"2005","unstructured":"Allard L.; Burkhard P.R.; Lescuyer P.; Burgess J.A.; Walter N.; Hochstrasser D.F.; Sanchez J.C.; PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke. Clin Chem 2005,51(11),2043-2051","journal-title":"Clin Chem"},{"key":"ref=199","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jns.2010.09.023","volume":"300","author":"Weissman J.D.","year":"2011","unstructured":"Weissman J.D.; Khunteev G.A.; Heath R.; Dambinova S.A.; NR2 antibodies: Risk assessment of transient ischemic attack (TIA)\/stroke in patients with history of isolated and multiple cerebrovascular events. J Neurol Sci 2011,300(1-2),97-102","journal-title":"J Neurol Sci"},{"key":"ref=200","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1046\/j.1365-2141.2000.02164.x","volume":"110","author":"Endler G.","year":"2000","unstructured":"Endler G.; Lalouschek W.; Exner M.; Mitterbauer G.; H\u00e4ring D.; Mannhalter C.; The 4G\/4G genotype at nucleotide position \u2212675 in the promotor region of the plasminogen activator inhibitor 1 (PAI-1) gene is less frequent in young patients with minor stroke than in controls. Br J Haematol 2000,110(2),469-471","journal-title":"Br J Haematol"},{"key":"ref=201","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1111\/ijs.12603","volume":"10","author":"George P.M.","year":"2015","unstructured":"George P.M.; Mlynash M.; Adams C.M.; Kuo C.J.; Albers G.W.; Olivot J.M.; Novel TIA biomarkers identified by mass spectrometry-based proteomics. Int J Stroke 2015,10(8),1204-1211","journal-title":"Int J Stroke"},{"key":"ref=202","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jns.2015.03.032","volume":"352","author":"Li Y.M.","year":"2015","unstructured":"Li Y.M.; Liu X.Y.; Serum levels of procalcitonin and high sensitivity C-reactive protein are associated with long-term mortality in acute ischemic stroke. J Neurol Sci 2015,352(1-2),68-73","journal-title":"J Neurol Sci"},{"key":"ref=203","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1212\/WNL.0000000000001938","volume":"85","author":"Lin J.","year":"2015","unstructured":"Lin J.; Zheng H.; Cucchiara B.L.; Li J.; Zhao X.; Liang X.; Wang C.; Li H.; Mullen M.T.; Johnston S.C.; Wang Y.; Wang Y.; Association of Lp-PLA  -A and early recurrence of vascular events after TIA and minor stroke. Neurology 2015,85(18),1585-1591","journal-title":"Neurology"},{"key":"ref=204","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1600-0404.2006.00715.x","volume":"115","author":"Purroy F.","year":"2007","unstructured":"Purroy F.; Montaner J.; Molina C.A.; Delgado P.; Arenillas J.F.; Chacon P.; Quintana M.; Alvarez-Sabin J.; C-reactive protein predicts further ischemic events in transient ischemic attack patients. Acta Neurol Scand 2007,115(1),60-66","journal-title":"Acta Neurol Scand"},{"key":"ref=205","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1212\/01.wnl.0000436937.32410.32","volume":"81","author":"Garc\u00eda-Berrocoso T.","year":"2013","unstructured":"Garc\u00eda-Berrocoso T.; Giralt D.; Bustamante A.; Etgen T.; Jensen J.K.; Sharma J.C.; Shibazaki K.; Saritas A.; Chen X.; Whiteley W.N.; Montaner J.; B-type natriuretic peptides and mortality after stroke: A systematic review and meta-analysis. Neurology 2013,81(23),1976-1985","journal-title":"Neurology"},{"key":"ref=206","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1161\/STROKEAHA.115.011035","volume":"47","author":"Folsom A.R.","year":"2016","unstructured":"Folsom A.R.; Gottesman R.F.; Appiah D.; Shahar E.; Mosley T.H.; Plasma d-dimer and incident ischemic stroke and coronary heart disease: The atherosclerosis risk in communities study. Stroke 2016,47(1),18-23","journal-title":"Stroke"},{"key":"ref=207","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1111\/ene.14419","volume":"27","author":"Tian X.","year":"2020","unstructured":"Tian X.; Guo Y.; Wang X.; Pei L.; Wang X.; Wu J.; Sun S.; Li Y.; Ning M.; Buonanno F.S.; Xu Y.; Song B.; Serum soluble ST2 is a potential long-term prognostic biomarker for transient ischaemic attack and ischaemic stroke. Eur J Neurol 2020,27(11),2202-2208","journal-title":"Eur J Neurol"},{"key":"ref=208","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.clinbiochem.2014.07.010","volume":"47","author":"Martinic-Popovic I.","year":"2014","unstructured":"Martinic-Popovic I.; Simundic A.M.; Dukic L.; Lovrencic-Huzjan A.; Popovic A.; Seric V.; Basic-Kes V.; Demarin V.; The association of inflammatory markers with cerebral vasoreactivity and carotid atherosclerosis in transient ischaemic attack. Clin Biochem 2014,47(16-17),182-186","journal-title":"Clin Biochem"},{"key":"ref=209","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1212\/WNL.0000000000001093","volume":"84","author":"a) Jov\u00e9 M.","year":"2015","unstructured":"a) Jov\u00e9 M.; Mauri-Capdevila G.; Su\u00e1rez I.; Cambray S.; Sanahuja J.; Qu\u00edlez A.; Farr\u00e9 J.; Benabdelhak I.; Pamplona R.; Portero-Ot\u00edn M.; Purroy F.; Metabolomics predicts stroke recurrence after transient ischemic attack. Neurology 2015,84(1),36-45","journal-title":"Neurology"},{"key":"ref=210","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s12013-015-0553-4","volume":"72","author":"Lu L.","year":"2015","unstructured":"Lu L.; Liu M.; Sun R.; Zheng Y.; Zhang P.; Myocardial infarction: Symptoms and treatments. Cell Biochem Biophys 2015,72(3),865-867","journal-title":"Cell Biochem Biophys"},{"key":"ref=211","first-page":"224","volume":"73","author":"Scheen A.J.","year":"2018","unstructured":"Scheen A.J.; From atherosclerosis to atherothrombosis: From a pathology chronic silence to an accident acute critique.  Rev Med Liege 2018,73(5-6),224-228","journal-title":"Rev Med Liege"},{"key":"ref=212","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1093\/eurheartj\/ehs105","volume":"33","author":"Taylor J.","year":"2012","unstructured":"Taylor J.; Third universal definition of myocardial infarction. Eur Heart J 2012,33(20),2506-2507","journal-title":"Eur Heart J"},{"key":"ref=213","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","volume":"360","author":"Lewington S.","year":"2002","unstructured":"Lewington S.; Clarke R.; Qizilbash N.; Peto R.; Collins R.; Prospective Studies C.; Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002,360(9349),1903-1913","journal-title":"Lancet"},{"key":"ref=214","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1001\/archinte.158.12.1326","volume":"158","author":"Nj\u00f8lstad I.","year":"1998","unstructured":"Nj\u00f8lstad I.; Arnesen E.; Preinfarction blood pressure and smoking are determinants for a fatal outcome of myocardial infarction: A prospective analysis from the Finnmark Study. Arch Intern Med 1998,158(12),1326-1332","journal-title":"Arch Intern Med"},{"key":"ref=215","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1177\/000456329603300601","volume":"33","author":"Tormey W.P.","year":"1996","unstructured":"Tormey W.P.; The diagnosis and management of acute myocardial infarction-a role for biochemical markers? Ann Clin Biochem 1996,33(6),477-481","journal-title":"Ann Clin Biochem"},{"key":"ref=216","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1093\/clinchem\/45.7.1104","volume":"45","author":"Wu A.H.B.","year":"1999","unstructured":"Wu A.H.B.; Apple F.S.; Gibler W.B.; Jesse R.L.; Warshaw M.M.; Valdes R.; National academy of clinical biochemistry standards of laboratory practice: Recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem 1999,45(7),1104-1121","journal-title":"Clin Chem"},{"key":"ref=217","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ijcard.2004.10.031","volume":"104","author":"Khan I.A.","year":"2005","unstructured":"Khan I.A.; Wattanasuwan N.; Role of biochemical markers in diagnosis of myocardial infarction. Int J Cardiol 2005,104(2),238-240","journal-title":"Int J Cardiol"},{"key":"ref=218","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12872-019-1008-4","volume":"19","author":"Tan B.","year":"2019","unstructured":"Tan B.; Liu Q.; Yang L.; Yang Y.; Liu D.; Liu L.; Meng F.; Low expression of PRMT5 in peripheral blood may serve as a potential independent risk factor in assessments of the risk of stable CAD and AMI. BMC Cardiovasc Disord 2019,19(1),31","journal-title":"BMC Cardiovasc Disord"},{"key":"ref=219","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nature13917","volume":"518","author":"Do R.","year":"2015","unstructured":"Do R.; Stitziel N.O.; Won H.H.; J\u00f8rgensen A.B.; Duga S.; Angelica Merlini P.; Kiezun A.; Farrall M.; Goel A.; Zuk O.; Guella I.; Asselta R.; Lange L.A.; Peloso G.M.; Auer P.L.; Girelli D.; Martinelli N.; Farlow D.N.; DePristo M.A.; Roberts R.; Stewart A.F.R.; Saleheen D.; Danesh J.; Epstein S.E.; Sivapalaratnam S.; Kees Hovingh G.; Kastelein J.J.; Samani N.J.; Schunkert H.; Erdmann J.; Shah S.H.; Kraus W.E.; Davies R.; Nikpay M.; Johansen C.T.; Wang J.; Hegele R.A.; Hechter E.; Marz W.; Kleber M.E.; Huang J.; Johnson A.D.; Li M.; Burke G.L.; Gross M.; Liu Y.; Assimes T.L.; Heiss G.; Lange E.M.; Folsom A.R.; Taylor H.A.; Olivieri O.; Hamsten A.; Clarke R.; Reilly D.F.; Yin W.; Rivas M.A.; Donnelly P.; Rossouw J.E.; Psaty B.M.; Herrington D.M.; Wilson J.G.; Rich S.S.; Bamshad M.J.; Tracy R.P.; Adrienne Cupples L.; Rader D.J.; Reilly M.P.; Spertus J.A.; Cresci S.; Hartiala J.; Wilson Tang W.H.; Hazen S.L.; Allayee H.; Reiner A.P.; Carlson C.S.; Kooperberg C.; Jackson R.D.; Boerwinkle E.; Lander E.S.; Schwartz S.M.; Siscovick D.S.; McPherson R.; Tybjaerg-Hansen A.; Abecasis G.R.; Watkins H.; Nickerson D.A.; Ardissino D.; Sunyaev S.R.; O\u2019Donnell C.J.; Altshuler D.; Gabriel S.; Kathiresan S.; Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction. Nature 2015,518(7537),102-106","journal-title":"Nature"},{"key":"ref=220","doi-asserted-by":"publisher","first-page":"5072","DOI":"10.1016\/j.ygeno.2020.09.004","volume":"112","author":"Mujalli A.","year":"2020","unstructured":"Mujalli A.; Banaganapalli B.; Alrayes N.M.; Shaik N.A.; Elango R.; Al-Aama J.Y.; Myocardial infarction biomarker discovery with integrated gene expression, pathways and biological networks analysis. Genomics 2020,112(6),5072-5085","journal-title":"Genomics"},{"key":"ref=221","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1111\/ene.13943","volume":"26","author":"Wang A.","year":"2019","unstructured":"Wang A.; Zhang X.; Li S.; Zhao X.; Liu L.; Johnston S.C.; Meng X.; Lin J.; Zuo Y.; Li H.; Wang Y.; Wang Y.; Oxidative lipoprotein markers predict poor functional outcome in patients with minor stroke or transient ischaemic attack. Eur J Neurol 2019,26(8),1082-1090","journal-title":"Eur J Neurol"},{"key":"ref=222","doi-asserted-by":"publisher","first-page":"e50926","DOI":"10.1371\/journal.pone.0050926","volume":"7","author":"Long G.","year":"2012","unstructured":"Long G.; Wang F.; Duan Q.; Yang S.; Chen F.; Gong W.; Yang X.; Wang Y.; Chen C.; Wang D.W.; Circulating miR-30a, miR-195 and let-7b associated with acute myocardial infarction. PLoS One 2012,7(12),e50926","journal-title":"PLoS One"},{"key":"ref=223","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/6121696","volume":"2019","author":"Zhao J.","year":"2019","unstructured":"Zhao J.; Yu H.; Yan P.; Zhou X.; Wang Y.; Yao Y.; Circulating MicroRNA-499 as a diagnostic biomarker for acute myocardial infarction: A meta-analysis. Dis Markers 2019,2019,1-10","journal-title":"Dis Markers"},{"key":"ref=224","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1161\/CIRCGENETICS.110.957415","volume":"3","author":"Corsten M.F.","year":"2010","unstructured":"Corsten M.F.; Dennert R.; Jochems S.; Kuznetsova T.; Devaux Y.; Hofstra L.; Wagner D.R.; Staessen J.A.; Heymans S.; Schroen B.; Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet 2010,3(6),499-506","journal-title":"Circ Cardiovasc Genet"},{"key":"ref=225","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1161\/CIRCGENETICS.110.958975","volume":"4","author":"Kuwabara Y.","year":"2011","unstructured":"Kuwabara Y.; Ono K.; Horie T.; Nishi H.; Nagao K.; Kinoshita M.; Watanabe S.; Baba O.; Kojima Y.; Shizuta S.; Imai M.; Tamura T.; Kita T.; Kimura T.; Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circ Cardiovasc Genet 2011,4(4),446-454","journal-title":"Circ Cardiovasc Genet"},{"key":"ref=226","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.bbrc.2009.11.005","volume":"391","author":"Ai J.","year":"2010","unstructured":"Ai J.; Zhang R.; Li Y.; Pu J.; Lu Y.; Jiao J.; Li K.; Yu B.; Li Z.; Wang R.; Wang L.; Li Q.; Wang N.; Shan H.; Li Z.; Yang B.; Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem Biophys Res Commun 2010,391(1),73-77","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=227","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3109\/00365519009091580","volume":"50","author":"Jensen A.E.","year":"1990","unstructured":"Jensen A.E.; Reikvam \u00c5.; \u00c5sberg A.; Diagnostic efficiency of lactate dehydrogenase isoenzymes in serum after acute myocardial infarction. Scand J Clin Lab Invest 1990,50(3),285-289","journal-title":"Scand J Clin Lab Invest"},{"key":"ref=228","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10654-018-0457-x","volume":"34","author":"Xuan Y.","year":"2019","unstructured":"Xuan Y.; Bobak M.; Anusruti A.; Jansen E.H.J.M.; Paj\u0105k A.; Tamosiunas A.; Saum K.U.; Holleczek B.; Gao X.; Brenner H.; Sch\u00f6ttker B.; Association of serum markers of oxidative stress with myocardial infarction and stroke: Pooled results from four large European cohort studies. Eur J Epidemiol 2019,34(5),471-481","journal-title":"Eur J Epidemiol"},{"key":"ref=229","first-page":"680","volume":"40","author":"Hawkins R.C.","year":"1999","unstructured":"Hawkins R.C.; Tan H.L.; Comparison of the diagnostic utility of CK, CK-MB (activity and mass), troponin T and troponin I in patients with suspected acute myocardial infarction. Singapore Med J 1999,40(11),680-684","journal-title":"Singapore Med J"},{"key":"ref=230","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.abb.2010.10.013","volume":"505","author":"Wei B.","year":"2011","unstructured":"Wei B.; Jin J.P.; Troponin T isoforms and posttranscriptional modifications: Evolution, regulation and function. Arch Biochem Biophys 2011,505(2),144-154","journal-title":"Arch Biochem Biophys"},{"key":"ref=231","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.amjmed.2014.10.056","volume":"128","author":"Shah A.S.V.","year":"2015","unstructured":"Shah A.S.V.; McAllister D.A.; Mills R.; Lee K.K.; Churchhouse A.M.D.; Fleming K.M.; Layden E.; Anand A.; Fersia O.; Joshi N.V.; Walker S.; Jaffe A.S.; Fox K.A.A.; Newby D.E.; Mills N.L.; Sensitive troponin assay and the classification of myocardial infarction. Am J Med 2015,128(5),493-501.e3","journal-title":"Am J Med"},{"key":"ref=232","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ijcard.2012.01.081","volume":"164","author":"Aldous S.J.","year":"2013","unstructured":"Aldous S.J.; Cardiac biomarkers in acute myocardial infarction. Int J Cardiol 2013,164(3),282-294","journal-title":"Int J Cardiol"},{"key":"ref=233","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jacc.2009.01.076","volume":"54","author":"Reichlin T.","year":"2009","unstructured":"Reichlin T.; Hochholzer W.; Stelzig C.; Laule K.; Freidank H.; Morgenthaler N.G.; Bergmann A.; Potocki M.; Noveanu M.; Breidthardt T.; Christ A.; Boldanova T.; Merki R.; Schaub N.; Bingisser R.; Christ M.; Mueller C.; Incremental value of copeptin for rapid rule out of acute myocardial infarction. J Am Coll Cardiol 2009,54(1),60-68","journal-title":"J Am Coll Cardiol"},{"key":"ref=234","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1161\/01.CIR.93.11.1963","volume":"93","author":"Omland T.","year":"1996","unstructured":"Omland T.; Aakvaag A.; Bonarjee V.V.S.; Caidahl K.; Lie R.T.; Nilsen D.W.T.; Sundsfjord J.A.; Dickstein K.; Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 1996,93(11),1963-1969","journal-title":"Circulation"},{"key":"ref=235","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1016\/0735-1097(96)00067-8","volume":"27","author":"Arakawa N.","year":"1996","unstructured":"Arakawa N.; Nakamura M.; Aoki H.; Hiramori K.; Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction. J Am Coll Cardiol 1996,27(7),1656-1661","journal-title":"J Am Coll Cardiol"},{"key":"ref=236","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1042\/CS20040087","volume":"107","author":"Squire I.B.","year":"2004","unstructured":"Squire I.B.; O\u2019Brien R.J.; Demme B.; Davies J.E.; Ng L.L.; N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction. Clin Sci (Lond) 2004,107(3),309-316","journal-title":"Clin Sci (Lond)"},{"key":"ref=237","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1093\/clinchem\/43.8.1372","volume":"43","author":"Ishii J.","year":"1997","unstructured":"Ishii J.; Wang J.; Naruse H.; Taga S.; Kinoshita M.; Kurokawa H.; Iwase M.; Kondo T.; Nomura M.; Nagamura Y.; Watanabe Y.; Hishida H.; Tanaka T.; Kawamura K.; Serum concentrations of myoglobin vs. human heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction. Clin Chem 1997,43(8),1372-1378","journal-title":"Clin Chem"},{"key":"ref=238","first-page":"CJ-12","volume":"2002","author":"Matsumoto S.","year":"2012","unstructured":"Matsumoto S.; Nakatani D.; Sakata Y.; Suna S.; Shimizu M.; Usami M.; Elevated serum heart-type fatty acid-binding protein in the convalescent stage predicts long-term outcome in patients surviving acute myocardial infarction. Circ J 2012,2002,CJ-12-CJ-0999","journal-title":"Circ J"},{"key":"ref=239","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1161\/CIRCRESAHA.116.304653","volume":"116","author":"Liebetrau C.","year":"2015","unstructured":"Liebetrau C.; Hoffmann J.; D\u00f6rr O.; Gaede L.; Blumenstein J.; Biermann H.; Pyttel L.; Thiele P.; Troidl C.; Berkowitsch A.; Rolf A.; Voss S.; Hamm C.W.; Nef H.; M\u00f6llmann H.; Release kinetics of inflammatory biomarkers in a clinical model of acute myocardial infarction. Circ Res 2015,116(5),867-875","journal-title":"Circ Res"},{"key":"ref=240","doi-asserted-by":"publisher","first-page":"e005637","DOI":"10.1161\/JAHA.117.005637","volume":"6","author":"Fanola C.L.","year":"2017","unstructured":"Fanola C.L.; Morrow D.A.; Cannon C.P.; Jarolim P.; Lukas M.A.; Bode C.; Hochman J.S.; Goodrich E.L.; Braunwald E.; O\u2019Donoghue M.L.; Interleukin-6 and the risk of adverse outcomes in patients after an acute coronary syndrome: Observations from the SOLID-TIMI 52 (stabilization of plaque using Darapladib\u2014Thrombolysis in Myocardial Infarction 52) trial. J Am Heart Assoc 2017,6(10),e005637","journal-title":"J Am Heart Assoc"},{"key":"ref=241","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.trsl.2016.04.005","volume":"176","author":"Napole\u00e3o P.","year":"2016","unstructured":"Napole\u00e3o P.; Cabral L.B.P.; Selas M.; Freixo C.; Monteiro M.C.; Criado M.B.; Costa M.C.; Enguita F.J.; Viegas-Crespo A.M.; Saldanha C.; Carmo M.M.; Ferreira R.C.; Pinheiro T.; Stratification of ST-elevation myocardial infarction patients based on soluble CD40L longitudinal changes. Transl Res 2016,176,95-104","journal-title":"Transl Res"},{"key":"ref=242","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.atherosclerosis.2016.01.022","volume":"246","author":"Lisowska A.","year":"2016","unstructured":"Lisowska A.; Knapp M.; Tyci\u0144ska A.; Motybel E.; Kami\u0144ski K.; \u015awi\u0119cki P.; Musia\u0142 W.J.; Dymicka-Piekarska V.; Predictive value of Galectin-3 for the occurrence of coronary artery disease and prognosis after myocardial infarction and its association with carotid IMT values in these patients: A mid-term prospective cohort study. Atherosclerosis 2016,246,309-317","journal-title":"Atherosclerosis"},{"key":"ref=243","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.tibs.2017.01.004","volume":"42","author":"Liu X.","year":"2017","unstructured":"Liu X.; Locasale J.W.; Metabolomics: A primer. Trends Biochem Sci 2017,42(4),274-284","journal-title":"Trends Biochem Sci"},{"key":"ref=244","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1124\/jpet.102.047092","volume":"305","author":"Shi Q.","year":"2003","unstructured":"Shi Q.; Savage J.E.; Hufeisen S.J.; Rauser L.; Grajkowska E.; Ernsberger P.; Wroblewski J.T.; Nadeau J.H.; Roth B.L.; L-homocysteine sulfinic acid and other acidic homocysteine derivatives are potent and selective metabotropic glutamate receptor agonists. J Pharmacol Exp Ther 2003,305(1),131-142","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=245","doi-asserted-by":"publisher","first-page":"154051","DOI":"10.1016\/j.metabol.2019.154051","volume":"104","author":"Khan A.","year":"2020","unstructured":"Khan A.; Choi Y.; Back J.H.; Lee S.; Jee S.H.; Park Y.H.; High-resolution metabolomics study revealing l-homocysteine sulfinic acid, cysteic acid, and carnitine as novel biomarkers for high acute myocardial infarction risk. Metabolism 2020,104,154051","journal-title":"Metabolism"},{"key":"ref=246","doi-asserted-by":"publisher","first-page":"667","DOI":"10.2174\/138920011796504536","volume":"12","author":"Pekala J.","year":"2011","unstructured":"Pekala J.; Patkowska-Soko\u0142a B.; Bodkowski R.; Jamroz D.; Nowakowski P.; Lochy\u0144ski S.; Librowski T.; L-carnitine--metabolic functions and meaning in humans life. Curr Drug Metab 2011,12(7),667-678","journal-title":"Curr Drug Metab"},{"key":"ref=247","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/j.metabol.2010.07.014","volume":"59","author":"Lenfant C.","year":"2010","unstructured":"Lenfant C.; Chest pain of cardiac and noncardiac origin. Metabolism 2010,59,S41-S46","journal-title":"Metabolism"},{"key":"ref=248","doi-asserted-by":"publisher","first-page":"831364","DOI":"10.1155\/2014\/831364","volume":"2014","author":"Tsaknis G.","year":"2014","unstructured":"Tsaknis G.; Tsangaris I.; Ikonomidis I.; Tsantes A.; Clinical usefulness of novel serum and imaging biomarkers in risk stratification of patients with stable angina. Dis Markers 2014,2014,831364","journal-title":"Dis Markers"},{"key":"ref=249","first-page":"16","volume":"11","author":"Romaschenko O.V.","year":"2020","unstructured":"Romaschenko O.V.; Snegin E.A.; Zhernakova N.I.; Alferov P.K.; Zakirova L.R.; Polymorphism of CYP2C9 gene in patients with stable angina pectoris and its significance in pathogenesis of the disease. Sys Rev Pharm 2020,11(6),16-20","journal-title":"Sys Rev Pharm"},{"key":"ref=250","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1177\/0003319711398862","volume":"62","author":"Amorim F.G.","year":"2011","unstructured":"Amorim F.G.; Campagnaro B.P.; Tonini C.L.; Norbim A.P.C.; Louro I.D.; Vasquez E.C.; Arruda J.A.; Meyrelles S.S.; Association of interleukin-6 gene polymorphism with angina pectoris. Angiology 2011,62(7),549-553","journal-title":"Angiology"},{"key":"ref=251","doi-asserted-by":"publisher","first-page":"22335","DOI":"10.1039\/C8RA01574K","volume":"8","author":"Ren J.L.","year":"2018","unstructured":"Ren J.L.; Zhang A.H.; Kong L.; Wang X.J.; Advances in mass spectrometry-based metabolomics for investigation of metabolites. RSC Advances 2018,8(40),22335-22350","journal-title":"RSC Advances"},{"key":"ref=252","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2217\/bmm-2019-0257","volume":"14","author":"Wang W.","year":"2020","unstructured":"Wang W.; Li T.; Gao L.; Li Y.; Sun Y.; Yao H.C.; Diagnostic and prognostic impact of circulating microRNA-208b and microRNA-499 in patients with acute coronary syndrome. Biomarkers Med 2020,14(2),87-95","journal-title":"Biomarkers Med"},{"key":"ref=253","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.5551\/jat.43166","volume":"25","author":"Yoshiyama T.","year":"2018","unstructured":"Yoshiyama T.; Sugioka K.; Naruko T.; Nakagawa M.; Shirai N.; Ohsawa M.; Yoshiyama M.; Ueda M.; Neopterin and cardiovascular events following coronary stent implantation in patients with stable angina pectoris. J Atheroscler Thromb 2018,25(11),1105-1117","journal-title":"J Atheroscler Thromb"},{"key":"ref=254","doi-asserted-by":"publisher","first-page":"110","DOI":"10.2174\/1874192401105010110","volume":"5","author":"Tanindi A.","year":"2011","unstructured":"Tanindi A.; Sahinarslan A.; Elbeg S.; Cemri M.; Relationship between MMP-1, MMP-9, TIMP-1, IL-6 and risk factors, clinical presentation, extent and severity of atherosclerotic coronary artery disease. Open Cardiovasc Med J 2011,5(1),110-116","journal-title":"Open Cardiovasc Med J"},{"key":"ref=255","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/tox.22454","volume":"33","author":"Zhang Y.","year":"2018","unstructured":"Zhang Y.; Li Y.; Shi C.; Fu X.; Zhao L.; Song Y.; Angiotensin-(1-7)-mediated Mas1 receptor\/NF-\u03baB-p65 signaling is involved in a cigarette smoke-induced chronic obstructive pulmonary disease mouse model. Environ Toxicol 2018,33(1),5-15","journal-title":"Environ Toxicol"},{"key":"ref=256","doi-asserted-by":"publisher","first-page":"e22179","DOI":"10.1002\/jcla.22179","volume":"32","author":"Lichtenauer M.","year":"2018","unstructured":"Lichtenauer M.; Wernly B.; Paar V.; Rohm I.; Jung C.; Yilmaz A.; Hoppe U.C.; Schulze P.C.; Kretzschmar D.; Pistulli R.; Specifics of fetuin-A levels in distinct types of chronic heart failure. J Clin Lab Anal 2018,32(1),e22179","journal-title":"J Clin Lab Anal"},{"key":"ref=257","doi-asserted-by":"publisher","first-page":"pdb.prot097527","DOI":"10.1101\/pdb.prot097527","volume":"2018","author":"Li C.","year":"2018","unstructured":"Li C.; Zamore P.D.; Preparation of antisense oligonucleotides to inhibit miRNA function. Cold Spring Harb Protoc 2018,2018(2),pdb.prot097527","journal-title":"Cold Spring Harb Protoc"},{"key":"ref=258","doi-asserted-by":"publisher","first-page":"e22457","DOI":"10.1002\/jcla.22457","volume":"32","author":"Karaba\u011f Y.","year":"2018","unstructured":"Karaba\u011f Y.; \u00c7a\u011fda\u015f M.; Rencuzogullari I.; Karakoyun S.; Arta\u00e7 \u0130.; \u0130li\u015f D.; Atalay E.; Yesin M.; G\u00fcrsoy M.O.; Halil Tanbo\u011fa I.; Relationship between C-reactive protein\/albumin ratio and coronary artery disease severity in patients with stable angina pectoris. J Clin Lab Anal 2018,32(7),e22457","journal-title":"J Clin Lab Anal"},{"key":"ref=259","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1039\/c3mb70216b","volume":"9","author":"Sun M.","year":"2013","unstructured":"Sun M.; Gao X.; Zhang D.; Ke C.; Hou Y.; Fan L.; Zhang R.; Liu H.; Li K.; Yu B.; Identification of biomarkers for unstable angina by plasma metabolomic profiling. Mol Biosyst 2013,9(12),3059-3067","journal-title":"Mol Biosyst"},{"key":"ref=260","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1093\/ndt\/gfs133","volume":"28","author":"Sun C.Y.","year":"2013","unstructured":"Sun C.Y.; Hsu H.H.; Wu M.S.; p-Cresol sulfate and indoxyl sulfate induce similar cellular inflammatory gene expressions in cultured proximal renal tubular cells. Nephrol Dial Transplant 2013,28(1),70-78","journal-title":"Nephrol Dial Transplant"},{"key":"ref=261","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.placenta.2010.09.002","volume":"31","author":"Dharane Ne\u00e9 Ligam P.","year":"2010","unstructured":"Dharane Ne\u00e9 Ligam P.; Manuelpillai U.; Wallace E.; Walker D.W.; NF\u03baB-dependent increase of kynurenine pathway activity in human placenta: Inhibition by sulfasalazine. Placenta 2010,31(11),997-1002","journal-title":"Placenta"},{"key":"ref=262","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","volume":"158","author":"Stevens P.E.","year":"2013","unstructured":"Stevens P.E.; Levin A.; Evaluation and management of chronic kidney disease: Synopsis of the kidney disease: Improving global outcomes 2012 clinical practice guideline. Ann Intern Med 2013,158(11),825-830","journal-title":"Ann Intern Med"},{"key":"ref=263","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/S0140-6736(17)30788-2","volume":"390","author":"Levin A.","year":"2017","unstructured":"Levin A.; Tonelli M.; Bonventre J.; Coresh J.; Donner J.A.; Fogo A.B.; Fox C.S.; Gansevoort R.T.; Heerspink H.J.L.; Jardine M.; Kasiske B.; K\u00f6ttgen A.; Kretzler M.; Levey A.S.; Luyckx V.A.; Mehta R.; Moe O.; Obrador G.; Pannu N.; Parikh C.R.; Perkovic V.; Pollock C.; Stenvinkel P.; Tuttle K.R.; Wheeler D.C.; Eckardt K.U.; Adu D.; Agarwal S.K.; Alrukhaimi M.; Anders H-J.; Ashuntantang G.; Basnet S.; Bello A.K.; Chailimpamontree W.; Correa-Rotter R.; Craig J.; Douthat W.G.; Feldman H.I.; Ganji M.R.; Garcia-Garcia G.; Gharbi M.B.; Harris D.C.; Jha V.; Johnson D.W.; Kazancioglu R.; Langham R.; Liu Z-H.; Massy Z.A.; Nangaku M.; Nelson R.G.; O\u2019Donoghue D.; Okpechi I.; Pecoits-Filho R.; Powe N.R.; Remuzzi G.; Roberts C.; Rossert J.; Sola L.; Stengel B.; M E.K.S.; Suzuki Y.; Tanaka T.; Tatiyanupanwong S.; Thomas B.; Uhlig K.; Walker R.; White S.L.; Wiecek A.; Yang C-W.; Global kidney health 2017 and beyond: A roadmap for closing gaps in care, research, and policy. Lancet 2017,390(10105),1888-1917","journal-title":"Lancet"},{"key":"ref=264","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/kisup.2012.73","volume":"3","author":"Levin A.","year":"2013","unstructured":"Levin A.; Stevens P.E.; Bilous R.W.; Coresh J.; De Francisco A.L.; De Jong P.E.; KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl Kidney disease: Improving global outcomes (KDIGO) CKD Work Group2013,3(1),1-150","journal-title":"Kidney Int Suppl"},{"key":"ref=265","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/5584_2016_84","volume":"956","author":"Hamrahian S.M.","year":"2016","unstructured":"Hamrahian S.M.; Falkner B.; Hypertension in chronic kidney disease. Adv Exp Med Biol 2016,956,307-325","journal-title":"Adv Exp Med Biol"},{"key":"ref=266","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s11886-012-0340-4","volume":"15","author":"Briasoulis A.","year":"2013","unstructured":"Briasoulis A.; Bakris G.L.; Chronic kidney disease as a coronary artery disease risk equivalent. Curr Cardiol Rep 2013,15(3),340","journal-title":"Curr Cardiol Rep"},{"key":"ref=267","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/S0140-6736(14)61601-9","volume":"385","author":"Liyanage T.","year":"2015","unstructured":"Liyanage T.; Ninomiya T.; Jha V.; Neal B.; Patrice H.M.; Okpechi I.; Zhao M.; Lv J.; Garg A.X.; Knight J.; Rodgers A.; Gallagher M.; Kotwal S.; Cass A.; Perkovic V.; Worldwide access to treatment for end-stage kidney disease: A systematic review. Lancet 2015,385(9981),1975-1982","journal-title":"Lancet"},{"key":"ref=268","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s10047-018-1059-9","volume":"22","author":"Kohlov\u00e1 M.","year":"2019","unstructured":"Kohlov\u00e1 M.; Amorim C.G.; Ara\u00fajo A.; Santos-Silva A.; Solich P.; Montenegro M.C.B.S.M.; The biocompatibility and bioactivity of hemodialysis membranes: Their impact in end-stage renal disease. J Artif Organs 2019,22(1),14-28","journal-title":"J Artif Organs"},{"key":"ref=269","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cca.2018.05.036","volume":"484","author":"Wei P.Z.","year":"2018","unstructured":"Wei P.Z.; Kwan B.C.H.; Chow K.M.; Cheng P.M.S.; Luk C.C.W.; Lai K.B.; Li P.K.T.; Szeto C.C.; Urinary mitochondrial DNA level in non-diabetic chronic kidney diseases. Clin Chim Acta 2018,484,36-39","journal-title":"Clin Chim Acta"},{"key":"ref=270","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1053\/j.ackd.2016.01.017","volume":"23","author":"Nadkarni G.N.","year":"2016","unstructured":"Nadkarni G.N.; Horowitz C.R.; Genomics in CKD: Is this the path forward? Adv Chronic Kidney Dis 2016,23(2),120-124","journal-title":"Adv Chronic Kidney Dis"},{"key":"ref=271","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/ng.232","volume":"40","author":"Kao W.H.L.","year":"2008","unstructured":"Kao W.H.L.; Klag M.J.; Meoni L.A.; Reich D.; Berthier-Schaad Y.; Li M.; Coresh J.; Patterson N.; Tandon A.; Powe N.R.; Fink N.E.; Sadler J.H.; Weir M.R.; Abboud H.E.; Adler S.G.; Divers J.; Iyengar S.K.; Freedman B.I.; Kimmel P.L.; Knowler W.C.; Kohn O.F.; Kramp K.; Leehey D.J.; Nicholas S.B.; Pahl M.V.; Schelling J.R.; Sedor J.R.; Thornley-Brown D.; Winkler C.A.; Smith M.W.; Parekh R.S.; MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 2008,40(10),1185-1192","journal-title":"Nat Genet"},{"key":"ref=272","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/ng.226","volume":"40","author":"Kopp J.B.","year":"2008","unstructured":"Kopp J.B.; Smith M.W.; Nelson G.W.; Johnson R.C.; Freedman B.I.; Bowden D.W.; Oleksyk T.; McKenzie L.M.; Kajiyama H.; Ahuja T.S.; Berns J.S.; Briggs W.; Cho M.E.; Dart R.A.; Kimmel P.L.; Korbet S.M.; Michel D.M.; Mokrzycki M.H.; Schelling J.R.; Simon E.; Trachtman H.; Vlahov D.; Winkler C.A.; MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 2008,40(10),1175-1184","journal-title":"Nat Genet"},{"key":"ref=273","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1193032","volume":"329","author":"Genovese G.","year":"2010","unstructured":"Genovese G.; Friedman D.J.; Ross M.D.; Lecordier L.; Uzureau P.; Freedman B.I.; Bowden D.W.; Langefeld C.D.; Oleksyk T.K.; Uscinski Knob A.L.; Bernhardy A.J.; Hicks P.J.; Nelson G.W.; Vanhollebeke B.; Winkler C.A.; Kopp J.B.; Pays E.; Pollak M.R.; Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010,329(5993),841-845","journal-title":"Science"},{"key":"ref=274","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/ki.2012.263","volume":"83","author":"Lipkowitz M.S.","year":"2013","unstructured":"Lipkowitz M.S.; Freedman B.I.; Langefeld C.D.; Comeau M.E.; Bowden D.W.; Linda Kao W.H.; Astor B.C.; Bottinger E.P.; Iyengar S.K.; Klotman P.E.; Freedman R.G.; Zhang W.; Parekh R.S.; Choi M.J.; Nelson G.W.; Winkler C.A.; Kopp J.B.; Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans. Kidney Int 2013,83(1),114-120","journal-title":"Kidney Int"},{"key":"ref=275","first-page":"3304","volume":"20","author":"Wang Y.X.","year":"2016","unstructured":"Wang Y.X.; Liu M.L.; Zhang B.; Fu E.Q.; Li Z.C.; Fasudil alleviated hypoxia-induced pulmonary hypertension by stabilizing the expression of angiotensin-(1-7) in rats. Eur Rev Med Pharmacol Sci 2016,20(15),3304-3312","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=276","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/ndt\/gfh574","volume":"20","author":"Szeto C.C.","year":"2005","unstructured":"Szeto C.C.; Chan R.W.Y.; Lai K.B.; Szeto C.Y.K.; Chow K.M.; Li P.K.T.; Lai F.M.M.; Messenger RNA expression of target genes in the urinary sediment of patients with chronic kidney diseases. Nephrol Dial Transplant 2005,20(1),105-113","journal-title":"Nephrol Dial Transplant"},{"key":"ref=277","first-page":"1219","volume":"11","author":"Song J.","year":"2019","unstructured":"Song J.; Yu J.; Prayogo G.W.; Cao W.; Wu Y.; Jia Z.; Zhang A.; Understanding kidney injury molecule 1: A novel immune factor in kidney pathophysiology. Am J Transl Res 2019,11(3),1219-1229","journal-title":"Am J Transl Res"},{"key":"ref=278","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/ki.2015.199","volume":"88","author":"Looker H.C.","year":"2015","unstructured":"Looker H.C.; Colombo M.; Hess S.; Brosnan M.J.; Farran B.; Dalton R.N.; Wong M.C.; Turner C.; Palmer C.N.A.; Nogoceke E.; Groop L.; Salomaa V.; Dunger D.B.; Agakov F.; McKeigue P.M.; Colhoun H.M.; Biomarkers of rapid chronic kidney disease progression in type 2 diabetes. Kidney Int 2015,88(4),888-896","journal-title":"Kidney Int"},{"key":"ref=279","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.3892\/etm.2015.2345","volume":"9","author":"Hu W.","year":"2015","unstructured":"Hu W.; Zhou P.H.; Zhang X.B.; Xu C.G.; Wang W.; Plasma concentrations of adrenomedullin and natriuretic peptides in patients with essential hypertension. Exp Ther Med 2015,9(5),1901-1908","journal-title":"Exp Ther Med"},{"key":"ref=280","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2337\/dc16-1571","volume":"40","author":"Saulnier P.J.","year":"2017","unstructured":"Saulnier P.J.; Gand E.; Velho G.; Mohammedi K.; Zaoui P.; Fraty M.; Halimi J.M.; Roussel R.; Ragot S.; Hadjadj S.; Association of circulating biomarkers (Adrenomedullin, TNFR1, and NT-proBNP) with renal function decline in patients with type 2 diabetes: A French prospective cohort. Diabetes Care 2017,40(3),367-374","journal-title":"Diabetes Care"},{"key":"ref=281","doi-asserted-by":"publisher","first-page":"8718","DOI":"10.1038\/s41598-020-65764-w","volume":"10","author":"Lumlertgul N.","year":"2020","unstructured":"Lumlertgul N.; Amprai M.; Tachaboon S.; Dinhuzen J.; Peerapornratana S.; Kerr S.J.; Srisawat N.; Urine neutrophil gelatinase-associated lipocalin (NGAL) for prediction of persistent AKI and major adverse kidney events. Sci Rep 2020,10(1),8718","journal-title":"Sci Rep"},{"key":"ref=282","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1093\/ajh\/hpz009","volume":"32","author":"Chen Y.","year":"2019","unstructured":"Chen Y.; Zhao W.; Liu C.; Meng W.; Zhao T.; Bhattacharya S.K.; Sun Y.; Molecular and cellular effect of angiotensin 1\u20137 on hypertensive kidney disease. Am J Hypertens 2019,32(5),460-467","journal-title":"Am J Hypertens"},{"key":"ref=283","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1093\/clinchem\/21.12.1777","volume":"21","author":"Koller A.","year":"1975","unstructured":"Koller A.; Aldwin L.; Natelson S.; Hepatic synthesis of canavaninosuccinate from ureidohomoserine and aspartate, and its conversion to guanidinosuccinate. Clin Chem 1975,21(12),1777-1782","journal-title":"Clin Chem"},{"key":"ref=284","doi-asserted-by":"publisher","first-page":"175ra29","DOI":"10.1126\/scitranslmed.3005218","volume":"5","author":"Berg AH","year":"2013","unstructured":"Berg AH; Drechsler C; Wenger J; Buccafusca R; Hod T; Kalim S.; Carbamylation of serum albumin as a risk factor for mortality in patients with kidney failure. Sci. Transl. Med. 2013,5(175),175ra29"},{"key":"ref=285","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1021\/pr300337s","volume":"11","author":"Wang X.","year":"2012","unstructured":"Wang X.; Wang X.; Xie G.; Zhou M.; Yu H.; Lin Y.; Du G.; Luo G.; Jia W.; Liu P.; Urinary metabolite variation is associated with pathological progression of the post-hepatitis B cirrhosis patients. J Proteome Res 2012,11(7),3838-3847","journal-title":"J Proteome Res"},{"key":"ref=286","doi-asserted-by":"publisher","first-page":"e6417","DOI":"10.1097\/MD.0000000000006417","volume":"96","author":"Qi H.","year":"2017","unstructured":"Qi H.; Liu Z.; Liu B.; Cao H.; Sun W.; Yan Y.; Zhang L.; micro-RNA screening and prediction model construction for diagnosis of salt-sensitive essential hypertension. Medicine (Baltimore) 2017,96(17),e6417","journal-title":"Medicine (Baltimore)"},{"key":"ref=287","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1161\/HYPERTENSIONAHA.113.01701","volume":"62","author":"Jackson K.L.","year":"2013","unstructured":"Jackson K.L.; Marques F.Z.; Watson A.M.D.; Palma-Rigo K.; Nguyen-Huu T.P.; Morris B.J.; Charchar F.J.; Davern P.J.; Head G.A.; A novel interaction between sympathetic overactivity and aberrant regulation of renin by miR-181a in BPH\/2J genetically hypertensive mice. Hypertension 2013,62(4),775-781","journal-title":"Hypertension"},{"key":"ref=288","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1161\/HYPERTENSIONAHA.111.180729","volume":"58","author":"Marques F.Z.","year":"2011","unstructured":"Marques F.Z.; Campain A.E.; Tomaszewski M.; Zukowska-Szczechowska E.; Yang Y.H.J.; Charchar F.J.; Morris B.J.; Gene expression profiling reveals renin mRNA overexpression in human hypertensive kidneys and a role for microRNAs. Hypertension 2011,58(6),1093-1098","journal-title":"Hypertension"},{"key":"ref=289","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ijpharm.2013.11.018","volume":"460","author":"Yu Y.","year":"2014","unstructured":"Yu Y.; Lu Y.; Bo R.; Huang Y.; Hu Y.; Liu J.; Wu Y.; Tao Y.; Wang D.; The preparation of gypenosides liposomes and its effects on the peritoneal macrophages function in vitro. Int J Pharm 2014,460(1-2),248-254","journal-title":"Int J Pharm"},{"key":"ref=290","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/jhh.2013.117","volume":"28","author":"Kontaraki J.E.","year":"2014","unstructured":"Kontaraki J.E.; Marketou M.E.; Zacharis E.A.; Parthenakis F.I.; Vardas P.E.; Differential expression of vascular smooth muscle-modulating microRNAs in human peripheral blood mononuclear cells: Novel targets in essential hypertension. J Hum Hypertens 2014,28(8),510-516","journal-title":"J Hum Hypertens"},{"key":"ref=291","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1053\/j.ajkd.2016.01.027","volume":"68","author":"Kwon S.H.","year":"2016","unstructured":"Kwon S.H.; Tang H.; Saad A.; Woollard J.R.; Lerman A.; Textor S.C.; Lerman L.O.; Differential expression of microRNAs in urinary extracellular vesicles obtained from hypertensive patients. Am J Kidney Dis 2016,68(2),331-332","journal-title":"Am J Kidney Dis"},{"key":"ref=292","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1161\/CIRCULATIONAHA.116.023926","volume":"134","author":"Li H.","year":"2016","unstructured":"Li H.; Zhang X.; Wang F.; Zhou L.; Yin Z.; Fan J.; Nie X.; Wang P.; Fu X.D.; Chen C.; Wang D.W.; MicroRNA-21 lowers blood pressure in spontaneous hypertensive rats by upregulating mitochondrial translation. Circulation 2016,134(10),734-751","journal-title":"Circulation"},{"key":"ref=293","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/jch.12797","volume":"18","author":"D\u00f6rr O.","year":"2016","unstructured":"D\u00f6rr O.; Liebetrau C.; M\u00f6llmann H.; Gaede L.; Troidl C.; Lankes S.; Guckel D.; Boeder N.; Voss S.; Bauer T.; Hamm C.; Nef H.; Effect of renal sympathetic denervation on specific MicroRNAs as an indicator of reverse remodeling processes in hypertensive heart disease. J Clin Hypertens (Greenwich) 2016,18(6),497-502","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref=294","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jash.2014.11.007","volume":"9","author":"van Deventer C.A.","year":"2015","unstructured":"van Deventer C.A.; Lindeque J.Z.; van Rensburg P.J.J.; Malan L.; van der Westhuizen F.H.; Louw R.; Use of metabolomics to elucidate the metabolic perturbation associated with hypertension in a black South African male cohort: The SABPA study. J Am Soc Hypertens 2015,9(2),104-114","journal-title":"J Am Soc Hypertens"},{"key":"ref=295","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00221-011-2925-3","volume":"216","author":"Shi G.","year":"2012","unstructured":"Shi G.; Liu Y.; Liu T.; Yan W.; Liu X.; Wang Y.; Shi J.; Jia L.; Upregulated miR-29b promotes neuronal cell death by inhibiting Bcl2L2 after ischemic brain injury. Exp Brain Res 2012,216(2),225-230","journal-title":"Exp Brain Res"},{"key":"ref=296","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.clineuro.2005.12.006","volume":"108","author":"Wunderlich M.T.","year":"2006","unstructured":"Wunderlich M.T.; Lins H.; Skalej M.; Wallesch C.W.; Goertler M.; Neuron-specific enolase and tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke. Clin Neurol Neurosurg 2006,108(6),558-563","journal-title":"Clin Neurol Neurosurg"},{"key":"ref=297","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.cca.2013.02.014","volume":"419","author":"Singh H.V.","year":"2013","unstructured":"Singh H.V.; Pandey A.; Shrivastava A.K.; Raizada A.; Singh S.K.; Singh N.; Prognostic value of neuron specific enolase and IL-10 in ischemic stroke and its correlation with degree of neurological deficit. Clin Chim Acta 2013,419,136-138","journal-title":"Clin Chim Acta"},{"key":"ref=298","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1002\/hep.28722","volume":"64","author":"Romeo S.","year":"2016","unstructured":"Romeo S.; Valenti L.; Regulation of retinol-binding protein 4 and retinol metabolism in fatty liver disease. Hepatology 2016,64(5),1414-1416","journal-title":"Hepatology"},{"key":"ref=299","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3390\/microorganisms7090340","volume":"7","author":"Sakurai T.","year":"2019","unstructured":"Sakurai T.; Odamaki T.; Xiao J.; Production of indole-3-lactic acid by Bifidobacterium strains isolated fromhuman infants. Microorganisms 2019,7(9),340","journal-title":"Microorganisms"},{"key":"ref=300","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0378-1097(00)00212-3","volume":"188","author":"Blin-Perrin C.","year":"2000","unstructured":"Blin-Perrin C.; Molle D.; Dufosse L.; Le-Quere J-L.; Viel C.; Mauvais G.; Feron G.; Metabolism of ricinoleic acid into \u03b3-decalactone: \u03b2-oxidation and long chain acyl intermediates of ricinoleic acid in the genus Sporidiobolus sp. FEMS Microbiol Lett 2000,188(1),69-74","journal-title":"FEMS Microbiol Lett"},{"key":"ref=301","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1271\/bbb.110303","volume":"75","author":"Mitsukura K.","year":"2011","unstructured":"Mitsukura K.; Suzuki M.; Shinoda S.; Kuramoto T.; Yoshida T.; Nagasawa T.; Purification and characterization of a novel (R)-imine reductase from Streptomyces sp. GF3587. Biosci Biotechnol Biochem 2011,75(9),1778-1782","journal-title":"Biosci Biotechnol Biochem"},{"key":"ref=302","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/chir.22237","volume":"25","author":"Vranova V.","year":"2013","unstructured":"Vranova V.; Lojkova L.; Rejsek K.; Formanek P.; Significance of the natural occurrence of L- versus D-pipecolic acid: A review. Chirality 2013,25(12),823-831","journal-title":"Chirality"},{"key":"ref=303","doi-asserted-by":"publisher","first-page":"25428","DOI":"10.1074\/jbc.M804146200","volume":"283","author":"Duncan R.E.","year":"2008","unstructured":"Duncan R.E.; Sarkadi-Nagy E.; Jaworski K.; Ahmadian M.; Sul H.S.; Identification and functional characterization of adipose-specific phospholipase A2 (AdPLA). J Biol Chem 2008,283(37),25428-25436","journal-title":"J Biol Chem"},{"key":"ref=304","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jacl.2019.02.004","volume":"13","author":"Zakiev E.","year":"2019","unstructured":"Zakiev E.; Rached F.; Lhomme M.; Darabi-Amin M.; Ponnaiah M.; Becker P.H.; Therond P.; Serrano C.V.; Santos R.D.; Chapman M.J.; Orekhov A.; Kontush A.; Distinct phospholipid and sphingolipid species are linked to altered HDL function in apolipoprotein A-I deficiency. J Clin Lipidol 2019,13(3),468-480.e8","journal-title":"J Clin Lipidol"},{"key":"ref=305","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.bbamem.2017.01.019","volume":"1859","author":"\u0160kolov\u00e1 B.","year":"2017","unstructured":"\u0160kolov\u00e1 B.; Kov\u00e1\u010dik A.; Tesa\u0159 O.; Op\u00e1lka L.; V\u00e1vrov\u00e1 K.; Phytosphingosine, sphingosine and dihydrosphingosine ceramides in model skin lipid membranes: Permeability and biophysics. Biochim Biophys Acta Biomembr 2017,1859(5),824-834","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"ref=306","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nbt.1759","volume":"29","author":"Bantscheff M.","year":"2011","unstructured":"Bantscheff M.; Hopf C.; Savitski M.M.; Dittmann A.; Grandi P.; Michon A.M.; Schlegl J.; Abraham Y.; Becher I.; Bergamini G.; Boesche M.; Delling M.; D\u00fcmpelfeld B.; Eberhard D.; Huthmacher C.; Mathieson T.; Poeckel D.; Reader V.; Strunk K.; Sweetman G.; Kruse U.; Neubauer G.; Ramsden N.G.; Drewes G.; Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes. Nat Biotechnol 2011,29(3),255-265","journal-title":"Nat Biotechnol"},{"key":"ref=307","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1210\/jc.2006-1869","volume":"92","author":"Razvi S.","year":"2007","unstructured":"Razvi S.; Ingoe L.; Keeka G.; Oates C.; McMillan C.; Weaver J.U.; The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: Randomized, crossover trial. J Clin Endocrinol Metab 2007,92(5),1715-1723","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=308","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1177\/0271678X19839501","volume":"40","author":"Cheng X.","year":"2020","unstructured":"Cheng X.; Ander B.P.; Jickling G.C.; Zhan X.; Hull H.; Sharp F.R.; Stamova B.; MicroRNA and their target mRNAs change expression in whole blood of patients after intracerebral hemorrhage. J Cereb Blood Flow Metab 2020,40(4),775-786","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref=309","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.jocn.2011.08.032","volume":"19","author":"Chiu C.C.","year":"2012","unstructured":"Chiu C.C.; Li Y.N.; Lin L.J.; Hsiao C.T.; Hsiao K.Y.; Chen I.C.; Serum D-dimer as a predictor of mortality in patients with acute spontaneous intracerebral hemorrhage. J Clin Neurosci 2012,19(6),810-813","journal-title":"J Clin Neurosci"},{"key":"ref=310","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.03.013","volume":"25","author":"Lee J.M.","year":"2016","unstructured":"Lee J.M.; Siddique J.; Kim H.C.; Green D.; Van Horn L.; Allison M.; Wassertheil-Smoller S.; Greenland P.; Hemostatic markers and long-term risk of intracerebral hemorrhage in postmenopausal women. J Stroke Cerebrovasc Dis 2016,25(7),1639-1643","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref=311","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.3389\/fneur.2018.01114","volume":"9","author":"Zhou Z.","year":"2018","unstructured":"Zhou Z.; Liang Y.; Zhang X.; Xu J.; Kang K.; Qu H.; Zhao C.; Zhao M.; Plasma D-Dimer concentrations and risk of intracerebral hemorrhage: A systematic review and meta-analysis. Front Neurol 2018,9,1114","journal-title":"Front Neurol"},{"key":"ref=312","doi-asserted-by":"publisher","first-page":"5846","DOI":"10.1111\/jcmm.14479","volume":"23","author":"Shao A.","year":"2019","unstructured":"Shao A.; Zhou Y.; Yao Y.; Zhang W.; Zhang J.; Deng Y.; The role and therapeutic potential of heat shock proteins in haemorrhagic stroke. J Cell Mol Med 2019,23(9),5846-5858","journal-title":"J Cell Mol Med"},{"key":"ref=313","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jneuroim.2019.03.007","volume":"330","author":"Zuo Z.","year":"2019","unstructured":"Zuo Z.; Ji X.; Prognostic value of copeptin in patients with aneurysmal subarachnoid hemorrhage. J Neuroimmunol 2019,330,116-122","journal-title":"J Neuroimmunol"},{"key":"ref=314","doi-asserted-by":"publisher","first-page":"AN20090063","DOI":"10.1042\/AN20090063","volume":"2","author":"Yanagisawa M.","year":"2010","unstructured":"Yanagisawa M.; Ariga T.; Yu R.K.; Cytotoxic effects of G(M1) ganglioside and amyloid \u03b2-peptide on mouse embryonic neural stem cells. ASN Neuro 2010,2(1),AN20090063","journal-title":"ASN Neuro"},{"key":"ref=315","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1159\/000333811","volume":"10","author":"Hernandez-Guillamon M.","year":"2012","unstructured":"Hernandez-Guillamon M.; Delgado P.; Penalba A.; Rodriguez-Luna D.; Molina C.A.; Rovira A.; Alvarez-Sabin J.; Boada M.; Montaner J.; Plasma \u03b2-amyloid levels in cerebral amyloid angiopathy-associated hemorrhagic stroke. Neurodegener Dis 2012,10(1-4),320-323","journal-title":"Neurodegener Dis"},{"key":"ref=316","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cca.2016.03.006","volume":"456","author":"Wang G.","year":"2016","unstructured":"Wang G.; Kwan B.C.H.; Lai F.M.M.; Chow K.M.; Ng K.C.J.; Luk C.W.C.; Li P.K.T.; Szeto C.C.; Urinary sediment mRNA level of extracellular matrix molecules in adult nephrotic syndrome. Clin Chim Acta 2016,456,157-162","journal-title":"Clin Chim Acta"},{"key":"ref=317","doi-asserted-by":"publisher","first-page":"e006939","DOI":"10.1161\/CIRCHEARTFAILURE.120.006939","volume":"13","author":"Wang K.","year":"2020","unstructured":"Wang K.; Basu R.; Poglitsch M.; Bakal J.A.; Oudit G.Y.; Elevated angiotensin 1\u20137\/Angiotensin II ratio predicts favorable outcomes in patients with heart failure. Circ Heart Fail 2020,13(7),e006939","journal-title":"Circ Heart Fail"},{"key":"ref=318","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.amjms.2019.02.011","volume":"357","author":"Acara A.C.","year":"2019","unstructured":"Acara A.C.; Bolatkale M.; Endothelial nitric oxide level as a predictor of coronary complexity in patients with unstable angina pectoris. Am J Med Sci 2019,357(6),453-460","journal-title":"Am J Med Sci"},{"key":"ref=319","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1056\/NEJMoa1214234","volume":"369","author":"Shlipak M.G.","year":"2013","unstructured":"Shlipak M.G.; Matsushita K.; \u00c4rnl\u00f6v J.; Inker L.A.; Katz R.; Polkinghorne K.R.; Rothenbacher D.; Sarnak M.J.; Astor B.C.; Coresh J.; Levey A.S.; Gansevoort R.T.; Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med 2013,369(10),932-943","journal-title":"N Engl J Med"},{"key":"ref=320","doi-asserted-by":"publisher","first-page":"4705","DOI":"10.21037\/jlpm.2017.12.06","volume":"2","author":"Shere A.","year":"2017","unstructured":"Shere A.; Eletta O.; Goyal H.; Circulating blood biomarkers in essential hypertension: A literature. JLPM 2017,2(12),4705","journal-title":"JLPM"},{"key":"ref=321","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/0886022X.2016.1256316","volume":"39","author":"\u010cabarkapa V.","year":"2017","unstructured":"\u010cabarkapa V.; Ilin\u010di\u0107 B.; \u0110eri\u0107 M.; Vu\u010daj \u0106irilovi\u0107 V.; Kresoja M.; \u017deravica R.; Saka\u010d V.; Cystatin C, vascular biomarkers and measured glomerular filtration rate in patients with unresponsive hypertensive phenotype: A pilot study. Ren Fail 2017,39(1),203-210","journal-title":"Ren Fail"},{"key":"ref=322","doi-asserted-by":"publisher","first-page":"e0193695","DOI":"10.1371\/journal.pone.0193695","volume":"13","author":"Ogawa-Akiyama A.","year":"2018","unstructured":"Ogawa-Akiyama A.; Sugiyama H.; Kitagawa M.; Tanaka K.; Onishi A.; Yamanari T.; Morinaga H.; Uchida H.A.; Nakamura K.; Ito H.; Wada J.; Serum cystatin C is an independent biomarker associated with the renal resistive index in patients with chronic kidney disease. PLoS One 2018,13(3),e0193695","journal-title":"PLoS One"},{"key":"ref=323","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12967-018-1693-2","volume":"16","author":"Lv L.","year":"2018","unstructured":"Lv L.; Wang J.; Gao B.; Wu L.; Wang F.; Cui Z.; He K.; Zhang L.; Chen M.; Zhao M.H.; Serum uromodulin and progression of kidney disease in patients with chronic kidney disease. J Transl Med 2018,16(1),316","journal-title":"J Transl Med"},{"key":"ref=324","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1159\/000507862","volume":"144","author":"Ostojic S.M.","year":"2020","unstructured":"Ostojic S.M.; Symmetric dimethylarginine as a secondary prevention biomarker of chronic kidney disease. Nephron J 2020,144(6),310-312","journal-title":"Nephron J"},{"key":"ref=325","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ekir.2018.09.013","volume":"4","author":"Alam M.L.","year":"2019","unstructured":"Alam M.L.; Katz R.; Bellovich K.A.; Bhat Z.Y.; Brosius F.C.; de Boer I.H.; Gadegbeku C.A.; Gipson D.S.; Hawkins J.J.; Himmelfarb J.; Kestenbaum B.R.; Kretzler M.; Robinson-Cohen C.; Steigerwalt S.P.; Tuegel C.; Bansal N.; Soluble ST2 and Galectin-3 and progression of CKD. Kidney Int Rep 2019,4(1),103-111","journal-title":"Kidney Int Rep"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867329666220921113403","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/209018\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867329666220921113403","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T19:56:05Z","timestamp":1693684565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/209018\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":325,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867329666220921113403","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-04-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-30","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}